+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Get PDF Full Texts from EurekaMag Chapter 46438

Chapter 46438 provides scholary research titles of which PDF Full Texts are available through EurekaMag.





Smith, R.M.; Giannoudis, P.V.; Bellamy, M.C.; Perry, S.L.; Dickson, R.A.; Guillou, P.J., 2000:
Interleukin-10 release and monocyte human leukocyte antigen-DR expression during femoral nailing

Bingisser, R.; Speich, R.; Zollinger, A.; Russi, E.; Frei, K., 2000:
Interleukin-10 secretion by alveolar macrophages and monocytes in sarcoidosis

Shames, B.D.; Selzman, C.H.; Meldrum, D.R.; Pulido, E.J.; Barton, H.A.; Meng, X.; Harken, A.H.; McIntyre, R.C., 1999:
Interleukin-10 stabilizes inhibitory kappaB-alpha in human monocytes

Sohn, B.H.; Moon, H.B.; Kim, T.Y.; Kang, H.S.; Bae, Y.S.; Lee, K.K.; Kim, S.J., 2001:
Interleukin-10 up-regulates tumour-necrosis-factor-alpha-related apoptosis-inducing ligand (TRAIL) gene expression in mammary epithelial cells at the involution stage

Lu, Y.; Hylander, B.; Brauner, A., 1996:
Interleukin-10, interferon gamma, interleukin-2, and soluble interleukin-2 receptor alpha detected during peritonitis in the dialysate and serum of patients on continuous ambulatory peritoneal dialysis

Ledeboer, A.; Brevé, J.J.; Poole, S.; Tilders, F.J.; Van Dam, A.M., 2000:
Interleukin-10, interleukin-4, and transforming growth factor-beta differentially regulate lipopolysaccharide-induced production of pro-inflammatory cytokines and nitric oxide in co-cultures of rat astroglial and microglial cells

Klava, A.; Windsor, A.C.; Farmery, S.M.; Woodhouse, L.F.; Reynolds, J.V.; Ramsden, C.W.; Boylston, A.W.; Guillou, P.J., 1997:
Interleukin-10. A role in the development of postoperative immunosuppression

Anonymous, 1999:
Interleukin-10. Cytokine synthesis inhibitory factor, SCH 52000, rIL-10, rhIL-10

Umetsu, D.T.; DeKruyff, R.H., 1999:
Interleukin-10: The missing link in asthma regulation?

Oberholzer, A.; Oberholzer, C.; Moldawer, L.L., 2002:
Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug

Tedgui, A.; Mallat, Z., 2001:
Interleukin-10: an anti-atherogenic cytokine?

Lalani, I.; Bhol, K.; Ahmed, A.R., 1998:
Interleukin-10: biology, role in inflammation and autoimmunity

Buchwald, U.K.; Geerdes-Fenge, H.F.; Vöckler, J.; Ziege, S.; Lode, H., 1999:
Interleukin-10: effects on phagocytosis and adhesion molecule expression of granulocytes and monocytes in a comparison with prednisolone

Parsons, P.E., 1998:
Interleukin-10: the ambiguity in sepsis continues

S.Clair, E.W., 2002:
Interleukin-10: therapeutic prospects in rheumatoid arthritis

Yang, Y.C., 1995:
Interleukin-11 (IL-11) and its receptor: biology and potential clinical applications in thrombocytopenic states

Xu, J.W.; Li, T.F.; Partsch, G.; Ceponis, A.; Santavirta, S.; Konttinen, Y.T., 1998:
Interleukin-11 (IL-11) in aseptic loosening of total hip replacement (THR)

Tanaka, T.; Sakamoto, T.; Miyama, M.; Ogita, S.; Umesaki, N., 2001:
Interleukin-11 enhances cell survival of decidualized normal human endometrial stromal cells

Kuenzler, K.A.; Pearson, P.Y.; Schwartz, M.Z., 2002:
Interleukin-11 enhances intestinal absorptive function after ischemia-reperfusion injury

Alavi, K.; Prasad, R.; Lundgren, K.; Schwartz, M.Z., 2000:
Interleukin-11 enhances small intestine absorptive function and mucosal mass after intestinal adaptation

Artz, A.S.; Ershler, W.B.; Rustgi, V., 2001:
Interleukin-11 for thrombocytopenia associated with hepatitis C

Schindel, D.; Maze, R.; Liu, Q.; Williams, D.; Grosfeld, J., 1997:
Interleukin-11 improves survival and reduces bacterial translocation and bone marrow suppression in burned mice

Anonymous, 1998:
Interleukin-11 product approved for chemotherapy support

Ameglio, F.; Bonifati, C.; Fazio, M.; Mussi, A.; Trento, E.; Cordial Fei, P.; Donati, P.; Pimpinelli, F.; D'Auria, L.; Carducci, M., 1997:
Interleukin-11 production is increased in organ cultures of lesional skin of patients with active plaque-type psoriasis as compared with nonlesional and normal skin. Similarity to interleukin-1 beta, interleukin-6 and interleukin-8

Hill, G.R.; Cooke, K.R.; Teshima, T.; Crawford, J.M.; Keith, J.C.; Brinson, Y.S.; Bungard, D.; Ferrara, J.L., 1998:
Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation

Maeda, T.; Yamada, Y., 2000:
Interleukin-11, 12, 13, 14, 15, 16, 17, 18 (IL-11, 12, 13, 14, 15, 16, 17, 18)

Trepicchio, W.L.; Dorner, A.J., 1999:
Interleukin-11. A gp130 cytokine

Stine, K.C.; Warren, B.A.; Becton, D.L., 1998:
Interleukin-12 (IL-12) enhances lysis of non-lymphoid leukemia cell lines in vitro

Hafner, M.; Falk, W.; Echtenacher, B.; Männel, D.N., 1999:
Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity

Ueta, C.; Kawasumi, H.; Fujiwara, H.; Miyagawa, T.; Kida, H.; Ohmoto, Y.; Kishimoto, S.; Tsuyuguchi, I., 1996:
Interleukin-12 activates human gamma delta T cells: synergistic effect of tumor necrosis factor-alpha

Alzona, M.; Jäck, H.M.; Simms, P.E.; Ellis, T.M., 1996:
Interleukin-12 activates interferon-gamma production by targeted activation of CD30+ T cells

Kobayashi, T.; Shiiba, K-ichi.; Satoh, M.; Hashimoto, W.; Mizoi, T.; Matsuno, S.; Takeda, K., 2002:
Interleukin-12 administration is more effective for preventing metastasis than for inhibiting primary established tumors in a murine model of spontaneous hepatic metastasis

Marinaro, M.; Boyaka, P.N.; Jackson, R.J.; Finkelman, F.D.; Kiyono, H.; McGhee, J.R., 1996:
Interleukin-12 alters helper T-cell subsets and antibody profiles induced by the mucosal adjuvant cholera toxin

Camporota, L.; Holloway, J.W., 1999:
Interleukin-12 and allergic tissue response

Mountford, A.P.; Pearlman, E., 1999:
Interleukin-12 and the host response to parasitic helminths; the paradoxical effect on protective immunity and immunopathology

Yang, Q.; Kuang, J.; Rao, W., 2002:
Interleukin-12 and the treatment of asthma

Gately, M.K.; Carvajal, D.M.; Connaughton, S.E.; Gillessen, S.; Warrier, R.R.; Kolinsky, K.D.; Wilkinson, V.L.; Dwyer, C.M.; Higgins, G.F.; Podlaski, F.J.; Faherty, D.A.; Familletti, P.C.; Stern, A.S.; Presky, D.H., 1996:
Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo

O'Toole, M.; Wooters, J.; Brown, E.; Swiniarski, H.; Cull, G.; Leger, L.; Herrmann, S., 1996:
Interleukin-12 as adjuvant in peptide vaccines

Skeen, M.J.; Miller, M.A.; Ziegler, H.K., 1996:
Interleukin-12 as an adjuvant in the generation of protective immunity to an intracellular pathogen

Tuo, W.; Palmer, G.H.; McGuire, T.C.; Zhu, D.; Brown, W.C., 1999:
Interleukin-12 as an adjuvant promotes immunoglobulin G and type 1 cytokine recall responses to major surface protein 2 of the ehrlichial pathogen Anaplasma marginale

Kumagai, K.; Takeda, K.; Hashimoto, W.; Seki, S.; Ogasawara, K.; Anzai, R.; Takahashi, M.; Sato, M.; Rikiishi, H., 1997:
Interleukin-12 as an inducer of cytotoxic effectors in anti-tumor immunity

Bliss, J.; Maylor, R.; Stokes, K.; Murray, K.S.; Ketchum, M.A.; Wolf, S.F., 1996:
Interleukin-12 as vaccine adjuvant. Characteristics of primary, recall, and long-term responses

Hiraki, A.; Kiura, K.; Yamane, H.; Nogami, N.; Tabata, M.; Takigawa, N.; Ueoka, H.; Tanimoto, M.; Harada, M., 2002:
Interleukin-12 augments cytolytic activity of peripheral blood mononuclear cells against autologous lung cancer cells in combination with IL-2

Kuriakose, M.A.; Chen, F.A.; Egilmez, N.K.; Jong, Y.S.; Mathiowitz, E.; DeLacure, M.D.; Hicks, W.L.; Loree, T.L.; Bankert, R.B., 1999:
Interleukin-12 delivered by biodegradable microspheres promotes the antitumor activity of human peripheral blood lymphocytes in a human head and neck tumor xenograft/SCID mouse model

Rothe, H.; Burkart, V.; Faust, A.; Kolb, H., 1996:
Interleukin-12 gene expression mediates the accelerating effect of cyclophosphamide in autoimmune disease

Myers, J.N.; Mank-Seymour, A.; Zitvogel, L.; Storkus, W.; Clarke, M.; Johnson, C.S.; Tahara, H.; Lotze, M.T., 1998:
Interleukin-12 gene therapy prevents establishment of SCC VII squamous cell carcinomas, inhibits tumor growth, and elicits long-term antitumor immunity in syngeneic C3H mice

Dunussi-Joannopoulos, K.; Leonard, J.P., 2001:
Interleukin-12 gene therapy vaccines: directing the immune system against minimal residual leukemia

Fu, J.; Zheng, J.; Fang, W., 2000:
Interleukin-12 gene transfection into murine B16 melanoma cells suppresses tumorigenicity and decreases metastatic potential

Weber, S.M.; Shi, F.; Heise, C.; Warner, T.; Mahvi, D.M., 1999:
Interleukin-12 gene transfer results in CD8-dependent regression of murine CT26 liver tumors

Sahin, U.; Kraft-Bauer, S.; Ohnesorge, S.; Pfreundschuh, M.; Renner, C., 1996:
Interleukin-12 increases bispecific-antibody-mediated natural killer cell cytotoxicity against human tumors

Ethuin, F.; Delarche, C.; Benslama, S.; Gougerot-Pocidalo, M.A.; Jacob, L.; Chollet-Martin, S., 2001:
Interleukin-12 increases interleukin 8 production and release by human polymorphonuclear neutrophils

Anzai, R.; Seki, S.; Ogasawara, K.; Hashimoto, W.; Sugiura, K.; Sato, M.; Kumagai, K.; Takeda, K., 1996:
Interleukin-12 induces cytotoxic NK1+ alpha beta T cells in the lungs of euthymic and athymic mice

Kawashima, T.; Kawasaki, H.; Kitamura, T.; Nojima, Y.; Morimoto, C., 1998:
Interleukin-12 induces tyrosine phosphorylation of an 85-kDa protein associated with the interleukin-12 receptor beta 1 subunit

Ye, Y-Ling.; Huang, W-Ching.; Lee, Y-Lun.; Chiang, B-Luen., 2002:
Interleukin-12 inhibits eotaxin secretion of cultured primary lung cells and alleviates airway inflammation in vivo

Yang, Y.; Han, S.Hyun.; Kim, H.; Kim, C.; Kim, K-yong.; Shin, S.Mi.; Choi, I.; Pyun, K.Ho., 2002:
Interleukin-12 p40 gene expression is induced in lipopolysaccharide-activated pituitary glands in vivo

de Mattos, A.M.; Meyer, M.M.; Norman, D.J.; Bennett, W.M.; Sprague, J.; Bakke, A.C., 1997:
Interleukin-12 p40 m-RNA expression in human kidney allograft biopsies

Kelsall, B.L.; Stüber, E.; Neurath, M.; Strober, W., 1996:
Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses

Reiss, C.S.; Komatsu, T.; Barna, M.; Bi, Z., 1996:
Interleukin-12 promotes enhanced recovery from viral infection of neurons in the central nervous system

Kishikawa, H.; Song, R.; Lawrence, D.A., 1998:
Interleukin-12 promotes enhanced resistance to Listeria monocytogenes infection of lead-exposed mice

Zeh, H.J.; Hurd, S.; Storkus, W.J.; Lotze, M.T., 1993:
Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer

Lio, D.; D'Anna, C.; Gervasi, F.; Scola, L.; Potestio, M.; Di Lorenzo, G.; Listì, F.; Colombo, A.; Candore, G.; Caruso, C., 1998:
Interleukin-12 release by mitogen-stimulated mononuclear cells in the elderly

Barton, D.P.; Blanchard, D.K.; Duan, C.; Roberts, W.S.; Cavanagh, D.; DeCesare, S.; Djeu, J.Y., 1995:
Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid

Shimizu, T.; Berhanu, A.; Redlinger, R.E.; Watkins, S.; Lotze, M.T.; Barksdale, E.M., 2001:
Interleukin-12 transduced dendritic cells induce regression of established murine neuroblastoma

Johnson, L.L.; Sayles, P.C., 1998:
Interleukin-12, dendritic cells, and the initiation of host-protective mechanisms against Toxoplasma gondii

Aharon-Maor, A.; Shoenfeld, Y., 1996:
Interleukin-12--polyfunctional cytokine

Quesniaux, V.F.; Ryffel, B., 1996:
Interleukin-12-induced interferon-gamma inhibits hematopoiesis in vivo in mice

Gately, M.K.; Brunda, M.J., 1995:
Interleukin-12: a pivotal regulator of cell-mediated immunity

Karp, C.L., 1999:
Interleukin-12: amiss in MS

Trinchieri, G.; Scott, P., 1999:
Interleukin-12: basic principles and clinical applications

Brunda, M.J.; Luistro, L.; Rumennik, L.; Wright, R.B.; Wigginton, J.M.; Wiltrout, R.H.; Hendrzak, J.A.; Palleroni, A.V., 1996:
Interleukin-12: murine models of a potent antitumor agent

Gately, M.K., 1997:
Interleukin-12: potential clinical applications in the treatment of chronic viral hepatitis

Yang, M-Soon.; Park, E.Jung.; Sohn, S.; Kwon, H.Jae.; Shin, W-Ho.; Pyo, H.Kyung.; Jin, B.; Choi, K.Sook.; Jou, I.; Joe, E-Hye., 2002:
Interleukin-13 and -4 induce death of activated microglia

Kotsimbos, T.C.; Ernst, P.; Hamid, Q.A., 1996:
Interleukin-13 and interleukin-4 are coexpressed in atopic asthma

Terada, N.; Hamano, N.; Nomura, T.; Numata, T.; Hirai, K.; Nakajima, T.; Yamada, H.; Yoshie, O.; Ikeda-Ito, T.; Konno, A., 2000:
Interleukin-13 and tumour necrosis factor-alpha synergistically induce eotaxin production in human nasal fibroblasts

Sternesjö, J.; Sandler, S., 1997:
Interleukin-13 counteracts suppression induced by interleukin-1beta of glucose metabolism but not of insulin secretion in rat pancreatic islets

Pawankar, R.U.; Okuda, M.; Hasegawa, S.; Suzuki, K.; Yssel, H.; Okubo, K.; Okumura, K.; Ra, C., 1995:
Interleukin-13 expression in the nasal mucosa of perennial allergic rhinitis

Wills-Karp, M.; Chiaramonte, M., 2002:
Interleukin-13 in asthma

Spadaro, A.; Rinaldi, T.; Riccieri, V.; Taccari, E.; Valesini, G., 2002:
Interleukin-13 in autoimmune rheumatic diseases: relationship with the autoantibody profile

Rogalewska, A.; Michalska, I.; Michno, T.; Chyrek-Borowska, S., 1999:
Interleukin-13 in the nasal lavage of pollinosis patients after specific intranasal challenge

Ruetten, H.; Thiemermann, C., 1998:
Interleukin-13 is a more potent inhibitor of the expression of inducible nitric oxide synthase in smooth muscle cells than in macrophages: a comparison with interleukin-4 and interleukin-10

Fiumara, P.; Cabanillas, F.; Younes, A., 2001:
Interleukin-13 levels in serum from patients with Hodgkin disease and healthy volunteers

Takahashi, Y.; Katayose, D.; Shindoh, C., 2000:
Interleukin-13 prevents diaphragm muscle deterioration in a septic animal model

Goebeler, M.; Schnarr, B.; Toksoy, A.; Kunz, M.; Bröcker, E.B.; Duschl, A.; Gillitzer, R., 1997:
Interleukin-13 selectively induces monocyte chemoattractant protein-1 synthesis and secretion by human endothelial cells. Involvement of IL-4R alpha and Stat6 phosphorylation

Matsukura, S.; Stellato, C.; Georas, S.N.; Casolaro, V.; Plitt, J.R.; Miura, K.; Kurosawa, S.; Schindler, U.; Schleimer, R.P., 2001:
Interleukin-13 upregulates eotaxin expression in airway epithelial cells by a STAT6-dependent mechanism

Vogel, G., 1999:
Interleukin-13's key role in asthma shown

McKenzie, A.N.; Zurawski, G., 1995:
Interleukin-13: characterization and biologic properties

Söderberg, O.; Christiansen, I.; Nilsson, G.; Carlsson, M.; Nilsson, K., 1997:
Interleukin-15 + thioredoxin induce DNA synthesis in B-chronic lymphocytic leukemia cells but not in normal B cells

Cassatella, M.A.; McDonald, P.P., 2000:
Interleukin-15 and its impact on neutrophil function

Kirman, I.; Vainer, B.; Nielsen, O.H., 1998:
Interleukin-15 and its role in chronic inflammatory diseases

Anether, G.; Marschitz, I.; Tinhofer, I.; Greil, R., 2002:
Interleukin-15 as a potential costimulatory cytokine in CD154 gene therapy of chronic lymphocytic leukemia

Lin, S.J.; Chao, H.C., 2001:
Interleukin-15 enhances CD4(+) CD45RA(+) expression on umbilical cord blood mononuclear cells

Leroy, S.; Dubois, S.; Tenaud, I.; Chebassier, N.; Godard, A.; Jacques, Y.; Dréno, B., 2001:
Interleukin-15 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome)

Yang, L.; Thornton, S.; Grom, A.A., 2002:
Interleukin-15 inhibits sodium nitroprusside-induced apoptosis of synovial fibroblasts and vascular endothelial cells

Inagaki-Ohara, K.; Nishimura, H.; Mitani, A.; Yoshikai, Y., 1997:
Interleukin-15 preferentially promotes the growth of intestinal intraepithelial lymphocytes bearing gamma delta T cell receptor in mice

Trentin, L.; Zambello, R.; Facco, M.; Sancetta, R.; Agostini, C.; Semenzato, G., 1997:
Interleukin-15: a novel cytokine with regulatory properties on normal and neoplastic B lymphocytes

Center, D.M.; Kornfeld, H.; Cruikshank, W.W., 1998:
Interleukin-16

Anonymous, 1996:
Interleukin-16 (IL-16). A terminology note. IUIS/WHO Standing Committee on Interleukin Designation

Kageyama, Y.; Ozeki, T.; Suzuki, M.; Ichikawa, T.; Miura, T.; Miyamoto, S.; Machida, A.; Nagano, A., 2000:
Interleukin-16 in synovial fluids from cases of various types of arthritis

Conti, P.; Kempuraj, D.; Kandere, K.; D.G.oacchino, M.; Reale, M.; Barbacane, R.C.; Castellani, M.L.; Mortari, U.; Boucher, W.; Letourneau, R.; Theoharides, T.C., 2002:
Interleukin-16 network in inflammation and allergy

Fossiez, F.; Banchereau, J.; Murray, R.; Van Kooten, C.; Garrone, P.; Lebecque, S., 1998:
Interleukin-17

Katz, Y.; Nadiv, O.; Beer, Y., 2001:
Interleukin-17 enhances tumor necrosis factor alpha-induced synthesis of interleukins 1,6, and 8 in skin and synovial fibroblasts: a possible role as a "fine-tuning cytokine" in inflammation processes

Katz, Y.; Nadiv, O., 2001:
Interleukin-17 may have a central role in inflammatory joint diseases as a "fine-tuning" cytokine

Kehlen, A.; Thiele, K.; Riemann, D.; Rainov, N.; Langner, J., 1999:
Interleukin-17 stimulates the expression of IkappaB alpha mRNA and the secretion of IL-6 and IL-8 in glioblastoma cell lines

Attur, M.G.; Patel, R.N.; Abramson, S.B.; Amin, A.R., 1997:
Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage

Kolls, J.K.; Kanaly, S.T.; Ramsay, A.J., 2002:
Interleukin-17: an emerging role in lung inflammation

Puren, A.J.; Fantuzzi, G.; Gu, Y.; Su, M.S.; Dinarello, C.A., 1998:
Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells

Wild, J.S.; Sur, S., 2001:
Interleukin-18 and allergic asthma

Fantuzzi, G.; Dinarello, C.A., 1999:
Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1)

Wollheim, F.A., 2000:
Interleukin-18 and new drugs. Protective effect against tumor growth and infections

Kawaguchi, Y.; Terajima, H.; Harigai, M.; Hara, M.; Kamatani, N., 2001:
Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease

Zecchina, G.; Novick, D.; Rubinstein, M.; Barak, V.; Dinarello, C.; Nagler, A., 2002:
Interleukin-18 binding protein in acute graft versus host disease and engraftment following allogeneic peripheral blood stem cell transplants

Whitman, S.C.; Ravisankar, P.; Daugherty, A., 2002:
Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma

Wang, W.; Tanaka, T.; Okamura, H.; Sugita, M.; Higa, S.; Kishimoto, T.; Suemura, M., 2001:
Interleukin-18 enhances the production of interleukin-8 by eosinophils

Burbach, G.J.; Naik, S.M.; Harten, J.B.; Liu, L.; Dithmar, S.; Grossniklaus, H.; Ward, S.L.; Armstrong, C.A.; Caughman, S.W.; Ansel, J.C., 2002:
Interleukin-18 expression and modulation in human corneal epithelial cells

Chan, E.D.; Choi, H-Seok.; Cool, C.; Accurso, F.J.; Fantuzzi, G., 2002:
Interleukin-18 expression in cystic fibrosis lungs

Takada, H.; Nomura, A.; Ohga, S.; Hara, T., 2001:
Interleukin-18 in hemophagocytic lymphohistiocytosis

Seta, Y.; Kanda, T.; Tanaka, T.; Arai, M.; Sekiguchi, K.; Yokoyama, T.; Kurimoto, M.; Tamura, J.; Kurabayashi, M., 2002:
Interleukin-18 in patients with congestive heart failure: induction of atrial natriuretic peptide gene expression

Oberholzer, A.; Steckholzer, U.; Kurimoto, M.; Trentz, O.; Ertel, W., 2002:
Interleukin-18 plasma levels are increased in patients with sepsis compared to severely injured patients

Affleck, D.G.; Bull, D.A.; Albanil, A.; Shao, Y.; Brady, J.; Karwande, S.V.; Eichwald, E.J.; Shelby, J., 2001:
Interleukin-18 production following murine cardiac transplantation: correlation with histologic rejection and the induction of INF-gamma

Dinarello, C.A., 2001:
Interleukin-18, a proinflammatory cytokine

McInnes, I.B.; Gracie, J.A.; Liew, F.Y., 2001:
Interleukin-18: a novel cytokine in inflammatory rheumatic disease

Crown, J.; Jakubowski, A.; Gabrilove, J., 1993:
Interleukin-1: biological effects in human hematopoiesis

Barone, E.J.; Yager, D.R.; Pozez, A.L.; Olutoye, O.O.; Crossland, M.C.; Diegelmann, R.F.; Cohen, I.K., 1998:
Interleukin-1alpha and collagenase activity are elevated in chronic wounds

Erdag, G.; Morgan, J.R., 2001:
Interleukin-1alpha and interleukin-6 enhance the antibacterial properties of cultured composite keratinocyte grafts

Englund, P.; Nennesmo, I.; Klareskog, L.; Lundberg, I.E., 2002:
Interleukin-1alpha expression in capillaries and major histocompatibility complex class I expression in type II muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflammatory cell clusters in muscle tissue

Gahring, L.C.; White, H.S.; Skradski, S.L.; Carlson, N.G.; Rogers, S.W., 1997:
Interleukin-1alpha in the brain is induced by audiogenic seizure

Tsan, M.F.; White, J.E., 1994:
Interleukin-1alpha induced protection against pulmonary oxygen toxicity

Zeki, K.; Morimoto, I.; Arao, T.; Eto, S.; Yamashita, U., 1998:
Interleukin-1alpha regulates G1 cell cycle progression and arrest in thyroid carcinoma cell lines NIM1 and NPA

Chang, C-Hsien.; Huang, Y.; Issekutz, A.C.; Griffith, M.; Lin, K-Hsiang.; Anderson, R., 2001:
Interleukin-1alpha released from epithelial cells after adenovirus type 37 infection activates intercellular adhesion molecule 1 expression on human vascular endothelial cells

Kubota, Y.; Ninomiya, T.; Oka, S.; Takenoshita, Y.; Shirasuna, K., 2000:
Interleukin-1alpha-dependent regulation of matrix metalloproteinase-9(MMP-9) secretion and activation in the epithelial cells of odontogenic jaw cysts

Blamire, A.M.; Anthony, D.C.; Rajagopalan, B.; Sibson, N.R.; Perry, V.H.; Styles, P., 2000:
Interleukin-1beta -induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: a magnetic resonance study

Ikegaya, Y.; Delcroix, I.; Iwakura, Y.; Matsuki, N.; Nishiyama, N., 2002:
Interleukin-1beta abrogates long-term depression of hippocampal CA1 synaptic transmission

Rzymkiewicz, D.M.; Tetsuka, T.; Daphna-Iken, D.; Srivastava, S.; Morrison, A.R., 1996:
Interleukin-1beta activates protein kinase C zeta in renal mesangial cells. Potential role in prostaglandin E2 up-regulation

Barkhordar, R.A.; Ghani, Q.Perveen.; Russell, T.R.; Hussain, M.Zamirul., 2002:
Interleukin-1beta activity and collagen synthesis in human dental pulp fibroblasts

Kuwagata, Y.; Oda, J.; Matsuyama, S.; Nishino, M.; Hashiguchi, N.; Ogura, H.; Tanaka, H.; Sugimoto, H., 2000:
Interleukin-1beta alters the oxygen delivery-oxygen consumption relationship in rabbits by increasing the slope of the supply-independent line

Tzannetou, S.; Efstratiadis, S.; Nicolay, O.; Grbic, J.; Lamster, I., 1999:
Interleukin-1beta and beta-glucuronidase in gingival crevicular fluid from molars during rapid palatal expansion

Zubareva, O.E.; Efremov, O.M.; Simbirtsev, A.S.; Klimenko, V.M., 2002:
Interleukin-1beta and depressive states

Billington, C.K.; Pascual, R.M.; Hawkins, M.L.; Penn, R.B.; Hall, I.P., 2001:
Interleukin-1beta and rhinovirus sensitize adenylyl cyclase in human airway smooth-muscle cells

Reynolds, A.M.; Holmes, M.D.; Scicchitano, R., 2002:
Interleukin-1beta and tumour necrosis factor-alpha increase microvascular leakage in the guinea pig trachea

Ataoğlu, T.; Ungör, M.; Serpek, B.; Haliloğlu, S.; Ataoğlu, H.; Ari, H., 2002:
Interleukin-1beta and tumour necrosis factor-alpha levels in periapical exudates

Wang, X-Feng.; Xing, F-Qi.; Chen, S-Ling., 2002:
Interleukin-1beta expression on ovarian granulosa cells and its clinical implication in women undergoing in vitro fertilization

Chen, W.C.; Wu, H.C.; Chen, H.Y.; Wu, M.C.; Hsu, C.D.; Tsai, F.J., 2002:
Interleukin-1beta gene and receptor antagonist gene polymorphisms in patients with calcium oxalate stones

Wang, Y.; Kato, N.; Hoshida, Y.; Yoshida, H.; Taniguchi, H.; Goto, T.; Moriyama, M.; Otsuka, M.; Shiina, S.; Shiratori, Y.; Ito, Y.; Omata, M., 2002:
Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection

Alstergren, P.; Ernberg, M.; Kvarnström, M.; Kopp, S., 1998 :
Interleukin-1beta in synovial fluid from the arthritic temporomandibular joint and its relation to pain, mobility, and anterior open bite

Andersen, H.U.; Fey, S.J.; Larsen, P.M.; Nawrocki, A.; Hejnaes, K.R.; Mandrup-Poulsen, T.; Nerup, J., 1998:
Interleukin-1beta induced changes in the protein expression of rat islets: a computerized database

Moon, M.R.; Parikh, A.A.; Pritts, T.A.; Kane, C.; Fischer, J.E.; Salzman, A.L.; Hasselgren, P.O., 2000:
Interleukin-1beta induces complement component C3 and IL-6 production at the basolateral and apical membranes in a human intestinal epithelial cell line

Stöve, J.; Huch, K.; Günther, K.P.; Scharf, H.P., 2001:
Interleukin-1beta induces different gene expression of stromelysin, aggrecan and tumor-necrosis-factor-stimulated gene 6 in human osteoarthritic chondrocytes in vitro

Suwatanapongched, P.; Laohapand, P.; Surarit, R.; Ohmoto, Y.; Ruxrungtham, K., 2001:
Interleukin-1beta level in gingival crevicular fluid of patients with active periodontitis

Lahat, E.; Livne, M.; Barr, J.; Katz, Y., 1997:
Interleukin-1beta levels in serum and cerebrospinal fluid of children with febrile seizures

Levine, D.F.; Witherspoon, D.E.; Gutmann, J.L.; Iacopino, A.M., 2001:
Interleukin-1beta production in periradicular lesions in a human immunodeficiency virus/acquired immune deficiency syndrome model compared with a noninfected host

Tobe, M.; Ogura, N.; Abiko, Y.; Nagura, H., 2002:
Interleukin-1beta stimulates interleukin-8 production and gene expression in synovial cells from human temporomandibular joint

Yang, W.S.; Kim, B.S.; Lee, S.K.; Park, J.S.; Kim, S.B., 1999:
Interleukin-1beta stimulates the production of extracellular matrix in cultured human peritoneal mesothelial cells

Gore, E.A.; Sanders, J.J.; Pandey, J.P.; Palesch, Y.; Galbraith, G.M., 1998:
Interleukin-1beta+3953 allele 2: association with disease status in adult periodontitis

Ataoglu, H.; Alptekin, N.Ozlem.; Haliloglu, S.; Gursel, M.; Ataoglu, T.; Serpek, B.; Durmus, E., 2002:
Interleukin-1beta, tumor necrosis factor-alpha levels and neutrophil elastase activity in peri-implant crevicular fluid

Haspolat, S.; Mihçi, E.; Coşkun, M.; Gümüslü, S.; Ozben, T.; Yeğin, O.; Ozbenm, T., 2003:
Interleukin-1beta, tumor necrosis factor-alpha, and nitrite levels in febrile seizures

Nasir, J.; Theilmann, J.L.; Vaillancourt, J.P.; Munday, N.A.; Ali, A.; Scherer, S.; Beatty, B.; Nicholson, D.W.; Hayden, M.R., 1997:
Interleukin-1beta-converting enzyme (ICE) and related cell death genes ICErel-II and ICErel-III map to the same PAC clone at band 11q22.2-22.3

Cuff, C.A.; Berman, J.W.; Brosnan, C.F., 2000:
Interleukin-1beta-induced expression of monocyte chemotactic protein-1 in the rabbit retina: an in situ and immunohistochemical study

Bach, L.W., 1996:
Interleukin-1beta-mediated beta-cell inhibition in vivo

Taguchi, T., 1994:
Interleukin-2 (IL-2)

Nishimura, T.; Taniyama, T., 2000:
Interleukin-2 (IL-2) and IL-2 receptor

Dănăilă, L.; Ghyka, G.; Ursaciuc, C., 1993:
Interleukin-2 (IL-2) in the treatment of malignant brain tumors (glioblastomas)

Rusterholz, C.; Henrioud, P.C.; Nabholz, M., 1999 :
Interleukin-2 (IL-2) regulates the accessibility of the IL-2-responsive enhancer in the IL-2 receptor alpha gene to transcription factors

Adachi, M.; Sekiya, M.; Torigoe, T.; Takayama, S.; Reed, J.C.; Miyazaki, T.; Minami, Y.; Taniguchi, T.; Imai, K., 1996:
Interleukin-2 (IL-2) upregulates BAG-1 gene expression through serine-rich region within IL-2 receptor beta c chain

Ascherman, D.P.; Migone, T.S.; Friedmann, M.C.; Leonard, W.J., 1997:
Interleukin-2 (IL-2)-mediated induction of the IL-2 receptor alpha chain gene. Critical role of two functionally redundant tyrosine residues in the IL-2 receptor beta chain cytoplasmic domain and suggestion that these residues mediate more than Stat5 activation

Anonymous, 2001:
Interleukin-2 (IL-2): a path toward functional eradication?

Anonymous, 2001:
Interleukin-2 (IL-2, Proleukin)

Fefer, A.; Benyunes, M.; Higuchi, C.; York, A.; Massumoto, C.; Lindgren, C.; Buckner, C.D.; Thompson, J.A., 1993:
Interleukin-2 +/- lymphocytes as consolidative immunotherapy after autologous bone marrow transplantation for hematologic malignancies

Katlama, C.; Carcelain, G.; Duvivier, C.; Chouquet, Cécile.; Tubiana, R.; D.S., M.; Zagury, L.; Calvez, V.; Autran, B.; Costagliola, D., 2002:
Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study--ANRS 082

Clamon, G.; Herndon, J.; Perry, M.C.; Ozer, H.; Kreisman, H.; Maher, T.; Ellerton, J.; Green, M.R., 1993:
Interleukin-2 activity in patients with extensive small-cell lung cancer: a phase II trial of Cancer and Leukemia Group B

Blidaru, A.; Bordea, C.I.; Viişoreanu, C.G.; Bordea, M.; Iliescu, I.; Duţescu, D.; Radu, F.; Drăgoescu, H., 2000:
Interleukin-2 alterations in the immune status of patients with mammary neoplasm

Huland, E., 2001:
Interleukin-2 and cancer--physiological and pharmacological uses

Agarwala, S.S.; Hellstrand, K.; Naredi, P., 2002:
Interleukin-2 and histamine dihydrochloride in metastatic melanoma

Hussenet, F.; Dousset, B.; Cordonnier, J.L.; Foliguet, B.; Grignon, G.; Nabet, P., 1993:
Interleukin-2 and human seminal fluid

Negrier, S.; Douillard, J-Yves.; Gomez, Fédéric.; Lasset, C.; Chevreau, C.; Escudier, B., 2002:
Interleukin-2 and interferon in metastatic kidney cancer. Experience of the French Immunotherapy Group

Breese, E.J.; Kumar, P.; Farthing, M.J.; MacDonald, T.T., 1994:
Interleukin-2 and interferon-gamma producing cells in the lamina propria in celiac disease

Thai, N.L.; Li, Y.; Fu, F.; Qian, S.; Demetris, A.J.; Duquesnoy, R.J.; Fung, J.J., 1997:
Interleukin-2 and interleukin-12 mediate distinct effector mechanisms of liver allograft rejection

Selezn'ov, K.H.; Barynov, E.F.; Iel's'kyĭ, K.V.; Ziablitsev, S.V., 2002:
Interleukin-2 and interleukin-4 blood levels in sinusitis

Kowal-Vern, A.; Walenga, J.M.; Hoppensteadt, D.; Sharp-Pucci, M.; Gamelli, R.L., 1994:
Interleukin-2 and interleukin-6 in relation to burn wound size in the acute phase of thermal injury

Lis, A.; Brzezińska-Wcisło, L., 2002:
Interleukin-2 and interleukin-6 in serum as markers of disease progression in systemic sclerosis

Hellmann, A., 1994 :
Interleukin-2 and its use in hemo-proliferative disorders

Mannering, S.I.; Cheers, C., 2001:
Interleukin-2 and loss of immunity in experimental Mycobacterium avium infection

Maes, M., 2000:
Interleukin-2 and schizophrenia

Anisimov, A.G.; Bolotnikov, I.A., 1998:
Interleukin-2 and staurosporine abolish inhibition of splenocyte nonspecific cytotoxicity caused by high doses of phorbol myristate acetate in rats

Sule, N.S.; Nerurkar, R.P.; Kamath, S., 2002:
Interleukin-2 as a therapeutic agent

Capelli; Nano; Civallero; Cerletti; Cremaschi; Nascimbene; Barni, 1998:
Interleukin-2 at different concentrations induces the growth of selective lymphoid cells

Anonymous, 2001:
Interleukin-2 clinical trials

Anonymous, 1996:
Interleukin-2 continues to show promise as HIV therapy

Summerfield, A.; Saalmüller, A., 1998:
Interleukin-2 dependent selective activation of porcine gamma delta T lymphocytes by an extract from the leaves of Acanthospermum hispidum

Caron, P.C.; Lai, L.T.; Scheinberg, D.A., 1995:
Interleukin-2 enhancement of cytotoxicity by humanized monoclonal antibody M195 (anti-CD33) in myelogenous leukemia

Romanelli, F., 1999:
Interleukin-2 for the management of HIV infection

Simmons, P., 2001:
Interleukin-2 for the treatment of HIV infection

Meloni, G.; Vignetti, M.; Andrizzi, C.; Capria, S.; Foa, R.; Mandelli, F., 1996:
Interleukin-2 for the treatment of advanced acute myelogenous leukemia patients with limited disease: updated experience with 20 cases

Zhang, X.; Huang, B.; Cai, L., 1995:
Interleukin-2 gene cloning and expression in S. cerevisiae

Heike, Y.; Takahashi, M.; Kanegae, Y.; Sato, Y.; Saito, I.; Saijo, N., 1997:
Interleukin-2 gene transduction into freshly isolated lung adenocarcinoma cells with adenoviral vectors

Larbre, B.; Nicolas, J.F.; Sarret, Y.; Tognet, E.; Mercatello, A.; Thivolet, J., 1993:
Interleukin-2 immunotherapy and cutaneous manifestations

Suc, E.; Neuville, S.; Lacombe, J.L.; Dumazer, P.; Tourani, J.M.; Bugat, R., 1995:
Interleukin-2 in a hemodialyzed patient with metastatic renal adenocarcinoma

Atkins, M.B., 1998:
Interleukin-2 in metastatic melanoma: establishing a role

Atkins, M.B., 2000:
Interleukin-2 in metastatic melanoma: what is the current role?

Fefer, A., 1998:
Interleukin-2 in the treatment of hematologic malignancies

Sznol, M.; Parkinson, D.R., 1994:
Interleukin-2 in therapy of hematologic malignancies

Capelli, E.; Civallero, M.; Barni, S.; Ceroni, M.; Nano, R., 2000:
Interleukin-2 induces the growth of human glioblastoma cells in culture

Jacobson, E.L.; Pilaro, F.; Smith, K.A., 1997:
Interleukin-2 infusions in HIV-infected patients

Anonymous, 1996:
Interleukin-2 injections produce sustained increases in CD4+ T cell counts in early-stage HIV disease

Lesur, O.; Kokis, A.; Hermans, C.; Fülöp, T.; Bernard, A.; Lane, D., 2001:
Interleukin-2 involvement in early acute respiratory distress syndrome: relationship with polymorphonuclear neutrophil apoptosis and patient survival

Kuroda, T.; Tanabe, N.; Sakatsume, M.; Nozawa, S.; Mitsuka, T.; Ishikawa, H.; Tohyama, C.T.; Nakazono, K.; Murasawa, A.; Nakano, M.; Gejyo, F., 2002:
Interleukin-2 levels are elevated in the bone marrow serum of patients with mutilans-type rheumatoid arthritis

Alonso, R.; Chaudieu, I.; Diorio, J.; Krishnamurthy, A.; Quirion, R.; Boksa, P., 1993:
Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells

Orvieto, R.; Bar-Hava, I.; Schwartz, A.; Shelef, M.; Ben-Rafael, Z., 1997:
Interleukin-2 production by human pre-implantation embryos

Taylor, H.G.; Nixon, N.B.; Dawes, P.T., 1993:
Interleukin-2 production in early rheumatoid arthritis

Kurashige, T.; Tomoda, T., 2000:
Interleukin-2 production test

Takakura, K., 1997:
Interleukin-2 receptor

Ascher, N.L., 1997:
Interleukin-2 receptor antibody therapy

Nakamura, M.; Asao, H.; Takeshita, T.; Sugamura, K., 1993:
Interleukin-2 receptor heterotrimer complex and intracellular signaling

Vincenti, F., 2001:
Interleukin-2 receptor monoclonal antibodies in renal transplantation: current use and emerging regimens

Romero-Adrián, T.; Ruiz, A.; Molina-Vílchez, R.; Estévez, Jús.; Atencio, R., 2002:
Interleukin-2 receptor serum concentrations in normal pregnancy and pre-eclampsia

Vanham, G.L.; Penne, G.; Vereecken, C.; Vingerhoets, J.; Kestens, L., 1998:
Interleukin-2 receptor subunit expression and function on human peripheral T cells is not dependent on the anticoagulant

Hoffmann, F.; Kruse, H.A.; Meinhold, H.; Bechrakis, N.E.; Heimann, H.; Diamanstein, T., 1994:
Interleukin-2 receptor--targeted therapy by monoclonal antibodies in the rat corneal graft

Strom, T.B.; Kelley, V.R.; Murphy, J.R.; Nichols, J.; Woodworth, T.G., 1994:
Interleukin-2 receptor-directed therapies: antibody- or cytokine-based targeting molecules

Strom, T.B.; Kelley, V.R.; Murphy, J.R.; Nichols, J.; Woodworth, T.G., 1993:
Interleukin-2 receptor-directed therapies: antibody-or cytokine-based targeting molecules

Rodriguez-Melendez, R.; Camporeale, G.; Griffin, J.B.; Zempleni, J., 2002:
Interleukin-2 receptor-gamma -dependent endocytosis depends on biotin in Jurkat cells

Yano, T.; Fukuyama, Y.; Yokoyama, H.; Takai, E.; Tanaka, Y.; Asoh, H.; Ichinose, Y., 1996:
Interleukin-2 receptors in pulmonary adenocarcinoma tissue

Song, P.; Lie-Cheng, W.; Wang, G.Du.; Zhou, Z.; Zhao, Z.Qi., 2003:
Interleukin-2 regulates membrane potentials and calcium channels via mu opioid receptors in rat dorsal root ganglion neurons

Radvanyi, L.G.; Raju, K.; Spaner, D.; Mills, G.B.; Miller, R.G., 1998:
Interleukin-2 reverses the defect in activation-induced apoptosis in T cells from autoimmune lpr mice

Nelson, B.H., 2002:
Interleukin-2 signaling and the maintenance of self-tolerance

Wang, G.F.; Zhu, Y.L.; Chen, J.K.; Zhang, W.H.; Zhong, Y.Q.; Hu, Y.Z.; Wang, F.Z., 2002:
Interleukin-2 stimulates the proliferation of cultured RC-4B/C pituitary adenoma cell line

Anonymous, 1995:
Interleukin-2 studies

Fefer, A.; Robinson, N.; Benyunes, M.C.; Bensinger, W.I.; Press, O.; Thompson, J.A.; Lindgren, C., 1998:
Interleukin-2 therapy after bone marrow or stem cell transplantation for hematologic malignancies

Letizia, M.; Conway, A.M., 1996:
Interleukin-2 therapy for renal cell cancer: indications, effects, and nursing implications

Pahwa, S.; Morales, M., 2001:
Interleukin-2 therapy in HIV infection

Meloni, G.; Vignetti, M.; Pogliani, E.; Invernizzi, R.; Allione, B.; Mirto, S.; Sica, S.; Leoni, F.; Selleri, C.; Mandelli, F., 1998:
Interleukin-2 therapy in relapsed acute myelogenous leukemia

Atkins, M.B., 1996:
Interleukin-2 therapy: a decade of slow but steady progress

Naglieri, E.; Lopez, M.; Lelli, G.; Morelli, F.; Amodio, A.; D.T.nno, P.; Gebbia, N.; D.S.ri, M.; Chetri, M.Concetta.; Rizzo, P.; Abbate, I.; Casamassima, A.; Selvaggi, F.Paolo.; Colucci, G., 2003:
Interleukin-2, interferon-alpha and medroxyprogesterone acetate in metastatic renal cell carcinoma

Waldmann, T.; Tagaya, Y.; Bamford, R., 1998:
Interleukin-2, interleukin-15, and their receptors

Rosenthal, A.J., 2000:
Interleukin-2, its receptor and nutrition in older adults: a review

Lissoni, P.; Pittalis, S.; Rovelli, F.; Vigorè, L.; Roselli, M.G.; Brivio, F., 1995:
Interleukin-2, melatonin and interleukin-12 as a possible neuroimmune combination in the biotherapy of cancer

Ott, M.; Demisch, L.; Engelhardt, W.; Fischer, P.A., 1993:
Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis

Margolin, K.A.; Van Besien, K.; Wright, C.; Niland, J.; Champlin, R.; Fung, H.C.; Kashyap, A.; Molina, A.; Nademanee, A.P.; O'Donnell, M.R.; Parker, P.; Smith, E.; Spielberger, R.; Somlo, G.; Snyder, D.; Stein, A.; Woo, D.; Thomas, M.; Sniecinski, I.; Forman, S.J., 1999:
Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphoma

Bjermer, L.; Grönberg, H.; Roos, G.; Henriksson, R., 1993:
Interleukin-2-administration intravenously and intrapleurally in a patient with primary pulmonary adenocarcinoma. Cellular responses in peripheral blood, intrapleural fluid and bronchoalveolar lavage

Figlin, R.; Gitlitz, B.; Franklin, J.; Dorey, F.; Moldawer, N.; Rausch, J.; deKernion, J.; Belldegrun, A., 1998:
Interleukin-2-based immunotherapy for the treatment of metastatic renal cell carcinoma: an analysis of 203 consecutively treated patients

Foa, R.; Meloni, G.; Guarini, A.; Vignetti, M.; Marchis, D.; Tosti, S.; Gillio Tos, A.; Mandelli, F.; Gavosto, F., 1993:
Interleukin-2-based immunotherapy in the management of minimal residual disease in acute leukemia patients

Dutcher, J.P.; Atkins, M.; Fisher, R.; Weiss, G.; Margolin, K.; Aronson, F.; Sosman, J.; Lotze, M.; Gordon, M.; Logan, T.; Mier, J., 1998:
Interleukin-2-based therapy for metastatic renal cell cancer: the Cytokine Working Group experience, 1989-1997

Boone, D.L.; Dassopoulos, T.; Lodolce, J.P.; Chai, S.; Chien, M.; Ma, A., 2002:
Interleukin-2-deficient mice develop colitis in the absence of CD28 costimulation

Moro, H.; Iwai, K.; Mori, N.; Watanabe, M.; Fukushi, M.; Oie, M.; Arai, M.; Tanaka, Y.; Miyawaki, T.; Gejyo, F.; Arakawa, M.; Fujii, M., 2002:
Interleukin-2-dependent but not independent T-cell lines infected with human T-cell leukemia virus type 1 selectively express CD45RO, a marker for persistent infection in vivo

Seiser, C.; Teixeira, S.; Kühn, L.C., 1993:
Interleukin-2-dependent transcriptional and post-transcriptional regulation of transferrin receptor mRNA

Horák, I., 1996:
Interleukin-2-knockout mice: a new model to study autoimmunity and self-tolerance

Kreisel, D.; Sankaran, D.; Wells, A.D.; Turka, L.A., 2002:
Interleukin-2-mediated survival and proliferative signals are uncoupled in T lymphocytes that fail to divide after activation

Vincenti, F.; Kirkman, R.; Light, S.; Bumgardner, G.; Pescovitz, M.; Halloran, P.; Neylan, J.; Wilkinson, A.; Ekberg, H.; Gaston, R.; Backman, L.; Burdick, J., 1998:
Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

Anonymous, 1993:
Interleukin-2: Advances in Clinical Research and Treatment. Proceedings of a meeting. Colorado Springs, Colorado, June 24-27, 1993

Oldham, 2000:
Interleukin-2: dose, schedule and route

Rubin, J.T., 1995:
Interleukin-2: its rationale and role in the treatment of patients with cancer

Ivanovski, N.; Popov, Z.; Kolevski, P.; Cakalaroski, K.; Spasovski, G.; Sikole, A.; Paneva-Masin, J., 2001:
Interleukin-2R antagonists in the prevention of acute rejection in living donor transplantation

Niho, Y.; Okamura, T.; Okamura, S., 1995:
Interleukin-3 (IL-3)

May, W.S.; Tyler, P.G.; Ito, T.; Armstrong, D.K.; Qatsha, K.A.; Davidson, N.E., 1994:
Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 alpha in association with suppression of apoptosis

Lindemann, A.; Mertelsmann, R., 1995:
Interleukin-3 and its receptor

Matulonis, U.; Salgia, R.; Okuda, K.; Druker, B.; Griffin, J.D., 1993:
Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line

Denzlinger, C.; Walther, J.; Wilmanns, W.; Gerhartz, H.H., 1993:
Interleukin-3 enhances the endogenous leukotriene production

Crump, M.; Couture, F.; Kovacs, M.; Saragosa, R.; McCrae, J.; Brandwein, J.; Huebsch, L.; Beauregard-Zollinger, L.; Keating, A., 1993:
Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation

Saavedra, H.I.; Wang, T.H.; Hoyt, P.R.; Popp, D.; Yang, W.K.; Stambrook, P.J., 1996:
Interleukin-3 increases the incidence of 5-azacytidine-induced thymic lymphomas in pBOR-Il-3 mice

Allen, J.S.; Eisma, R.; Leonard, G.; Kreutzer, D., 1997:
Interleukin-3 interleukin-5, and granulocyte-macrophage colony-stimulating factor expression in nasal polyps

Liu, C.B.; Arai, K., 1997:
Interleukin-3 receptor

Pasetto, N.; Ticconi, C.; Zicari, A.; Pontieri, G.; Piccione, E., 1993:
Interleukin-3 stimulates prostaglandin E2 release by human fetal membranes at term gestation

Miyairi, Y.; Murai, K.; Utsugisawa, T.; Narigasawa, Y.; Ito, S.; Shimosegawa, K.; Sugawara, T.; Numaoka, H.; Ono, Y.; Ito, T.; Ishida, Y.; Kuriya, S., 1996:
Interleukin-3 therapy in patients with aplastic anemia refractory to prior therapies

Weich, N.S.; Tullai, J.; Guido, E.; McMahon, M.; Jolliffe, L.K.; Lopez, A.F.; Vadas, M.A.; Lowry, P.A.; Quesenberry, P.J.; Rosen, J., 1993:
Interleukin-3/erythropoietin fusion proteins: in vitro effects on hematopoietic cells

Hoffman, R., 1993:
Interleukin-3: a potentially useful agent for treating chemotherapy-related thrombocytopenia

Nagai, N.; Kashiwamura, S.; Nakanishi, K.; Shinka, S., 1994:
Interleukin-4 (IL-4)

Taylor, D.J., 1994:
Interleukin-4 (IL-4) induces down-modulation and shedding of the p55 tumour necrosis factor receptor and inhibits TNF alpha's effect on rheumatoid synovial fibroblasts

Reittie, J.E.; Hoffbrand, A.V., 1994:
Interleukin-4 (IL-4) inhibits proliferation and spontaneous cytokine release by chronic lymphocytic leukaemia cells

Wang; Chen; Yazdani; Simon; Schwartz; Rabbani, 2000:
Interleukin-4 Modulation of Platelet-Derived Growth Factor-Induced Smooth Muscle Cell Urokinase Plasminogen Activator

Tam, F.W.; Smith, J.; Karkar, A.M.; Pusey, C.D.; Rees, A.J., 1997:
Interleukin-4 ameliorates experimental glomerulonephritis and up-regulates glomerular gene expression of IL-1 decoy receptor

Van Den Berg, Jé.G.; Aten, J.; Annink, C.; Ravesloot, J.H.; Weber, E.; Weening, J.J., 2001:
Interleukin-4 and -13 promote basolateral secretion of H(+) and cathepsin L by glomerular epithelial cells

Nagai, S.; Toi, M., 2000:
Interleukin-4 and breast cancer

Viac, J.; Gueniche, A.; Gatto, H.; Lizard, G.; Schmitt, D., 1994:
Interleukin-4 and interferon-gamma interactions in the induction of intercellular adhesion molecule-1 and major histocompatibility complex class II antigen expression of normal human keratinocytes

Pousset, F.; Cremona, S.; Dantzer, R.; Kelley, K.; Parnet, P., 1999:
Interleukin-4 and interleukin-10 regulate IL1-beta induced mouse primary astrocyte activation: a comparative study

Powrie, F.; Menon, S.; Coffman, R.L., 1993:
Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo

Chomarat, P.; Banchereau, J., 1999:
Interleukin-4 and interleukin-13: their similarities and discrepancies

Foster, P.S.; Hogan, S.P.; Matthaei, K.I.; Young, I.G., 1997:
Interleukin-4 and interleukin-5 as targets for the inhibition of eosinophilic inflammation and allergic airways hyperreactivity

Zhu, J.; Majumdar, S.; Qiu, Y.; Ansari, T.; Oliva, A.; Kips, J.C.; Pauwels, R.A.; D.R.se, V.; Jeffery, P.K., 2001:
Interleukin-4 and interleukin-5 gene expression and inflammation in the mucus-secreting glands and subepithelial tissue of smokers with chronic bronchitis. Lack of relationship with CD8(+) cells

Park, C.S.; Ra, D.J.; Lee, S.M.; Jeong, S.W.; Uh, S.; Kim, H.T.; Kim, Y.H., 1996:
Interleukin-4 and low-affinity receptor for IgE on B cells in peripheral blood of patients with atopic bronchial asthma

Rosenwasser, L.J., 1997:
Interleukin-4 and the genetics of atopy

Bry, K.; Lappalainen, U., 1994:
Interleukin-4 and transforming growth factor-beta 1 modulate the production of interleukin-1 receptor antagonist and of prostaglandin E2 by decidual cells

Hodge, S.; Hodge, G.; Holmes, M.; Flower, R.; Scicchitano, R., 2001:
Interleukin-4 and tumour necrosis factor-alpha inhibit transforming growth factor-beta production in a human bronchial epithelial cell line: possible relevance to inflammatory mechanisms in chronic obstructive pulmonary disease

Murphy, P.T.; Hutchinson, R.M., 1998:
Interleukin-4 and tumour necrosis factor-alpha produce non isotype specific partial differentiation of peripheral blood B-cells in myeloma

Matsumoto, K.; Ohi, H.; Kanmatsuse, K., 1999:
Interleukin-4 cooperates with interleukin-10 to inhibit vascular permeability factor release by peripheral blood mononuclear cells from patients with minimal-change nephrotic syndrome

Morga, E.; Heuschling, P., 1996:
Interleukin-4 down-regulates MHC class II antigens on cultured rat astrocytes

Okada, H.; Konishi, K.; Nakazato, Y.; Kanno, Y.; Suzuki, H.; Sakaguchi, H.; Saruta, T., 1994:
Interleukin-4 expression in mesangial proliferative glomerulonephritis

Hijazi, Z.; Haider, M.Z., 2000:
Interleukin-4 gene promoter polymorphism [C590T] and asthma in Kuwaiti Arabs

Mandt, N.; Geilen, C.C.; Wrobel, A.; Gelber, A.; Kamp, H.; Orfanos, C.E.; Blume-Peytavi, U., 2002:
Interleukin-4 induces apoptosis in cultured human follicular keratinocytes, but not in dermal papilla cells

Lee, C.E.; Park, H.J., 2001:
Interleukin-4 induces two distinct GAS-binding complexes containing STAT6: evidence for DNA binding of STAT6 monomer

Méndez-Samperio, P.; Badillo-Flores, A.; Nuñez-Vazquez, A.; Hernandez Garay, M., 1998:
Interleukin-4 inhibits secretion of interleukin-1beta in the response of human cells to mycobacterial heat shock proteins

Griga, T.; Hebler, U.; Voigt, E.; Tromm, A.; May, B., 2001:
Interleukin-4 inhibits the increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease

Tsai, F-Jen.; Chou, I-Ching.; Hsieh, Y-Yuan.; Lee, C-Chun.; Lin, C-Chieh.; Tsai, C-Hai., 2002:
Interleukin-4 intron 3 polymorphism is not related to susceptibility to febrile seizures

Dutcher, J.P.; Venkatraj, U.; Makower, D.; Wiernik, P.H., 1997:
Interleukin-4 is a pleotropic cytokine with effects on B-cell malignancies

Venkataraman, C.; Chelvarajan, R.L.; Cambier, J.C.; Bondada, S., 1999:
Interleukin-4 overcomes the negative influence of cyclic AMP accumulation on antigen receptor stimulated B lymphocytes

Ye, A.Yongxin.; Dou, Y.; Yang, X.; Wang, S.; Huang, A.Yue.; Wei, L., 2018:
A model for postzygotic mosaicisms quantifies the allele fraction drift, mutation rate, and contribution to de novo mutations

Michel, J.; Gonzáles, J.R.; Wunderlich, D.; Diete, A.; Herrmann, J.M.; Meyle, J., 2001:
Interleukin-4 polymorphisms in early onset periodontitis

Collins, H.; Flesch, I.E.; Emoto, M.; Kaufmann, S.H., 1999:
Interleukin-4 production in response to infection with intracellular bacteria

Madison, J.M.; Ethier, M.F., 2001:
Interleukin-4 rapidly inhibits calcium transients in response to carbachol in bovine airway smooth muscle cells

Hall, I.P., 2001:
Interleukin-4 receptor alpha gene variants and allergic disease

Nelms, K.; Huang, H.; Ryan, J.; Keegan, A.; Paul, W.E., 1999:
Interleukin-4 receptor signalling mechanisms and their biological significance

Tan, E.C.; Lee, B.W.; Tay, A.W.; Shek, L.; Chew, F.T.; Tay, A.H., 2000:
Interleukin-4 receptor variant Q576R: ethnic differences and association with atopy

Roy, S.; Charboneau, R.; Melnyk, D.; Barke, R.A., 2000:
Interleukin-4 regulates macrophage interleukin-12 protein synthesis through a c-fos mediated mechanism

Nishisaka, F.; Sohen, S.; Fukuoka, H.; Okamoto, Y.; Matukawa, M.; Fukuda, K.; Hamanishi, C., 2001:
Interleukin-4 reversed the Interleukin-1-inhibited proteoglycan synthesis through the inhibition of NO release: a possible involvement of intracellular calcium ion

Wei, S.; Wang, M.W-H.; Teitelbaum, S.L.; Ross, F.Patrick., 2001:
Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-kappa B and mitogen-activated protein kinase signaling

Roilides, E.; Kadiltsoglou, I.; Dimitriadou, A.; Hatzistilianou, M.; Manitsa, A.; Karpouzas, J.; Pizzo, P.A.; Walsh, T.J., 1997:
Interleukin-4 suppresses antifungal activity of human mononuclear phagocytes against Candida albicans in association with decreased uptake of blastoconidia

Anonymous, 1994:
Interleukin-4 tried for KS

Hoekstra, M.O.; Hoekstra, Y.; D.R.us, D.; Rutgers, B.; Gerritsen, J.; Kauffman, H.F., 1998:
Interleukin-4, interferon-gamma and interleukin-5 in peripheral blood of children with moderate atopic asthma

Mehindate, K.; al-Daccak, R.; Aoudjit, F.; Damdoumi, F.; Fortier, M.; Borgeat, P.; Mourad, W., 1996:
Interleukin-4, transforming growth factor beta 1, and dexamethasone inhibit superantigen-induced prostaglandin E2-dependent collagenase gene expression through their action on cyclooxygenase-2 and cytosolic phospholipase A2

Sonoda, Y., 1994:
Interleukin-4--a dual regulatory factor in hematopoiesis

Dokter, W.H.; Sierdsema, S.J.; Esselink, M.T.; Halie, M.R.; Vellenga, E., 1994:
Interleukin-4-mediated inhibition of C-Fos mRNA expression: role of the lipoxygenase directed pathway

Emoto, M.; Emoto, Y.; Kaufmann, S.H., 1995:
Interleukin-4-producing CD4+ NK1.1+ TCR alpha/beta intermediate liver lymphocytes are down-regulated by Listeria monocytogenes

Ando, M.; Miyazaki, E.; Fukami, T.; Kumamoto, T.; Tsuda, T., 1999:
Interleukin-4-producing cells in idiopathic pulmonary fibrosis: an immunohistochemical study

Ohmori, Y.; Hamilton, T.A., 2000:
Interleukin-4/STAT6 represses STAT1 and NF-kappa B-dependent transcription through distinct mechanisms

Yasue, T.; Kikuchi, Y.; Takatsu, K., 1995:
Interleukin-5 (IL-5)

Benson, M.; Strannegård, I.L.; Wennergren, G.; Strannegård, O., 1999:
Interleukin-5 and interleukin-8 in relation to eosinophils and neutrophils in nasal fluids from school children with seasonal allergic rhinitis

Roboz, G.J.; Rafii, S., 1999:
Interleukin-5 and the regulation of eosinophil production

Ramsay, A.J.; Kohonen-Corish, M., 1993:
Interleukin-5 expressed by a recombinant virus vector enhances specific mucosal IgA responses in vivo

Terada, N.; Konno, A.; Fukuda, S.; Yamashita, T.; Shirotori, K.; Okamoto, Y.; Ishikawa, K.; Togawa, K., 1994:
Interleukin-5 gene expression in nasal mucosa and changes in amount of interleukin-5 in nasal lavage fluid after antigen challenge

Schrezenmeier, H.; Thomé, S.D.; Tewald, F.; Fleischer, B.; Raghavachar, A., 1993:
Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome

Ishizuka, T.; Ishizuka, T.; Iwamae, S.; Hisada, T.; Okayama, Y.; Tsukagoshi, H.; Dobashi, K.; Mori, M., 2002:
Interleukin-5 messenger RNA expression in peripheral blood mononuclear cells from patients with bronchial asthma and eosinophilia

Terada, N.; Konno, A.; Natori, T.; Tada, H.; Togawa, K., 1993:
Interleukin-5 preferentially recruits eosinophils from vessels in nasal mucosa

Ogata, N.; Takatsu, K., 1997:
Interleukin-5 receptor

Lins, C.; Borojevic, R., 2002:
Interleukin-5 receptor alpha chain expression and splicing during brain development in mice

Sun, Z.; Yergeau, D.A.; Wong, I.C.; Tuypens, T.; Tavernier, J.; Paul, C.C.; Baumann, M.A.; Auron, P.E.; Tenen, D.G.; Ackerman, S.J., 1996:
Interleukin-5 receptor alpha subunit gene regulation in human eosinophil development: identification of a unique cis-element that acts lie an enhancer in regulating activity of the IL-5R alpha promoter

van der Bruggen, T.; Caldenhoven, E.; Kanters, D.; Coffer, P.; Raaijmakers, J.A.; Lammers, J.W.; Koenderman, L., 1995:
Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and Stat1 alpha

Huston, D.P.; Huston, M.M.; Dickason, R.R.; Martinez-Moczygemba, M., 2000:
Interleukin-5, a therapeutic target in allergic inflammation

Robinson, D.S., 1993:
Interleukin-5, eosinophils and bronchial hyperreactivity

Sanderson, C.J.; Urwin, D., 2001:
Interleukin-5: a drug target for allergic diseases

Blümchen, K.; Kallinich, T.; Hamelmann, E., 2001:
Interleukin-5: a novel target for asthma therapy

Weltman, J.K.; Karim, A.S., 1998 :
Interleukin-5: a proeosinophil cytokine mediator of inflammation in asthma and a target for antisense therapy

Takatsu, K., 1995:
Interleukin-5: an overview

Yokoyama, A., 1995:
Interleukin-6 (IL-6)

Yumoto, H.; Nakae, H.; Fujinaka, K.; Ebisu, S.; Matsuo, T., 1998:
Interleukin-6 (IL-6) and IL-8 are induced in human oral epithelial cells in response to exposure to periodontopathic Eikenella corrodens

Thier, M.; März, P.; Otten, U.; Weis, J.; Rose-John, S., 2000:
Interleukin-6 (IL-6) and its soluble receptor support survival of sensory neurons

März, P.; Heese, K.; Hock, C.; Golombowski, S.; Müller-Spahn, F.; Rose-John, S.; Otten, U., 1998:
Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients

Finkel, M.S.; Hoffman, R.A.; Shen, L.; Oddis, C.V.; Simmons, R.L.; Hattler, B.G., 1993:
Interleukin-6 (IL-6) as a mediator of stunned myocardium

Ishioka, S.; van Haaften-Day, C.; Sagae, S.; Kudo, R.; Hacker, N.F., 1999:
Interleukin-6 (IL-6) does not change the expression of Bcl-2 protein in the prevention of cisplatin-induced apoptosis in ovarian cancer cell lines

Yamakawa, Y.; Sugita, Y.; Nagatani, T.; Takahashi, S.; Yamakawa, T.; Tanaka, S.; Nakamura, S.; Ohno, S.; Sekihara, H.; Okuda, K.; Nakajima, H., 1996:
Interleukin-6 (IL-6) in patients with Behçet's disease

Hansen, T.G.; Tønnesen, E.; Toft, P.; Bendtzen, K., 1998:
Interleukin-6 (IL-6) is not removed from plasma during experimental haemofiltration

Romero, L.I.; Kakucska, I.; Lechan, R.M.; Reichlin, S., 1996:
Interleukin-6 (IL-6) is secreted from the brain after intracerebroventricular injection of IL-1 beta in rats

Ayroldi, E.; Zollo, O.; Cannarile, L.; D.A.amio, F.; Grohmann, U.; Delfino, D.V.; Riccardi, C., 1998:
Interleukin-6 (IL-6) prevents activation-induced cell death: IL-2-independent inhibition of Fas/fasL expression and cell death

Boyle-Walsh, E.; Hashim, I.A.; Speirs, V.; Fraser, W.D.; White, M.C., 1994:
Interleukin-6 (IL-6) production and cell growth of cultured human ameningiomas:-interactions with interleukin-1 beta (IL-1 beta) and interleukin-4 (IL-4) in vitro

Yoshida, S.; Sotozono, C.; Ikeda, T.; Kinoshita, S., 2001:
Interleukin-6 (IL-6) production by cytokine-stimulated human Müller cells

Sakamoto, K.; Ogawa, M.; Sakamoto, K., 1997:
Interleukin-6 (IL-6) receptor

Gadient, R.A.; Otten, U.H., 1997:
Interleukin-6 (IL-6)--a molecule with both beneficial and destructive potentials

Jüttler, E.; Tarabin, V.; Schwaninger, M., 2002:
Interleukin-6 (IL-6): a possible neuromodulator induced by neuronal activity

Dendorfer, U.; Oettgen, P.; Libermann, T.A., 1995:
Interleukin-6 Gene Expression by Prostaglandins and Cyclic AMP Mediated by Multiple Regulatory Elements

Chung, T.D.; Yu, J.J.; Kong, T.A.; Spiotto, M.T.; Lin, J.M., 1999:
Interleukin-6 activates phosphatidylinositol-3 kinase, which inhibits apoptosis in human prostate cancer cell lines

Fu, K.; Ma, X.; Zhang, Z., 1995:
Interleukin-6 activity in synovial fluids of temporomandibular joint distrubance syndrome

Igaz, P.; Tóth, S.; Madurka, I.; Falus, A., 1998:
Interleukin-6 acts in different ways via soluble and membrane-bound receptors

Alonzi, T.; Gorgoni, B.; Screpanti, I.; Gulino, A.; Poli, V., 1998:
Interleukin-6 and CAAT/enhancer binding protein beta-deficient mice act as tools to dissect the IL-6 signalling pathway and IL-6 regulation

Kobayashi, E.; Yamauchi, H., 1997:
Interleukin-6 and a delay of neutrophil apoptosis after major surgery

Svoboda, B.; Kanka, J.; Folauf, V.; Svárovský, J.; Kaspárková, H.; Musil, J.; Nováková, O.; Dvoráková, M.; Dyrynková, V., 1996:
Interleukin-6 and acute phase reactants in the diagnosis of ovarian carcinoma

Paule, B., 2001:
Interleukin-6 and bone metastasis of renal cancer: molecular bases and therapeutic implications

Gotteland, M.; Sáenz, R.; López, M.; Altshiller, H.; Llorens, P.; Brunser, O., 1999:
Interleukin-6 and interferon-gamma release from blood mononuclear cells and colonic mucosa from patients with ulcerative colitis

Fukuda, H.; Masuzaki, H.; Ishimaru, T., 2002:
Interleukin-6 and interleukin-1 receptor antagonist in amniotic fluid and cord blood in patients with pre-term, premature rupture of the membranes

Bell, M.J.; Kochanek, P.M.; Doughty, L.A.; Carcillo, J.A.; Adelson, P.D.; Clark, R.S.; Wisniewski, S.R.; Whalen, M.J.; DeKosky, S.T., 1997:
Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children

Lazzari, L.; Henschler, R.; Lecchi, L.; Rebulla, P.; Mertelsmann, R.; Sirchia, G., 2000:
Interleukin-6 and interleukin-11 act synergistically with thrombopoietin and stem cell factor to modulate ex vivo expansion of human CD41+ and CD61+ megakaryocytic cells

Rezai, A.R.; Rezai, A.; Martínez-Maza, O.; Vander-Meyden, M.; Weiss, M.H., 1994:
Interleukin-6 and interleukin-6 receptor gene expression in pituitary tumors

Jahnz-Rózyk, K.; Płusa, T.; Faber, M.; Stepnowski, L.; Pirozyńska, E.; Pojda, Z., 1996:
Interleukin-6 and interleukin-8 in bronchoalveolar lavage fluid material from patients with chronic bronchitis

Brauner, A.; Hylander, B.; Wretlind, B., 1993:
Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis

Kuang, Y.; Zhang, Z.; Zhang, X., 2000:
Interleukin-6 and its soluble receptors in human breast cancer

Deichmann, M.; Benner, A.; Waldmann, V.; Bock, M.; Jäckel, A.; Näher, H., 2001:
Interleukin-6 and its surrogate C-reactive protein are useful serum markers for monitoring metastasized malignant melanoma

Conti, P.; Kempuraj, D.; D.G.oacchino, M.; Boucher, W.; Letourneau, R.; Kandere, K.; Barbacane, R.C.; Reale, M.; Felaco, M.; Frydas, S.; Theoharides, T.C., 2002:
Interleukin-6 and mast cells

Raasveld, M.H.; Bloemena, E.; Wilmink, J.M.; Surachno, S.; Schellekens, P.T.; ten Berge, R.J., 1993:
Interleukin-6 and neopterin in renal transplant recipients: a longitudinal study

Heinrich, P.C.; Horn, F.; Graeve, L.; Dittrich, E.; Kerr, I.; Müller-Newen, G.; Grötzinger, J.; Wollmer, A., 1998:
Interleukin-6 and related cytokines: effect on the acute phase reaction

Spadaro, A.; Riccieri, V.; Sili Scavalli, A.; Sensi, F.; Fiore, D.; Taccari, E.; Zoppini, A., 1996:
Interleukin-6 and soluble interleukin-2 receptor in juvenile chronic arthritis: correlations with clinical and laboratory parameters

Spadaro, A.; Taccari, E.; Riccieri, V.; Sensi, F.; Sili Scavalli, A.; Zoppini, A., 1996:
Interleukin-6 and soluble interleukin-2-receptor in psoriatic arthritis: correlations with clinical and laboratory parameters

Nuttin, B., 1995:
Interleukin-6 and spinal cord damage in rats

Fukushima, R.; Kawamura, Y.J.; Saito, H.; Saito, Y.; Hashiguchi, Y.; Sawada, T.; Muto, T., 1996:
Interleukin-6 and stress hormone responses after uncomplicated gasless laparoscopic-assisted and open sigmoid colectomy

Gerber, A.; Wille, A.; Welte, T.; Ansorge, S.; Bühling, F., 2001:
Interleukin-6 and transforming growth factor-beta 1 control expression of cathepsins B and L in human lung epithelial cells

Kiefer, R.; Lindholm, D.; Kreutzberg, G.W., 1993:
Interleukin-6 and transforming growth factor-beta 1 mRNAs are induced in rat facial nucleus following motoneuron axotomy

Michalsky, M.P.; Deitch, E.A.; Ding, J.; Lu, Q.; Huang, Q., 1997:
Interleukin-6 and tumor necrosis factor production in an enterocyte cell model (Caco-2) during exposure to Escherichia coli

Rudolph, K.; Gourine, A.V.; Korsak, A.S.; Kluger, M.J., 1999:
Interleukin-6 and tumor necrosis factor-alpha during fever induced by bacterial infection

Xie, M.; Zhou, L.; Jin, X., 2000:
Interleukin-6 and tumor necrosis factor-alpha in middle ear effusions

Seifert, J.K.; Stewart, G.J.; Hewitt, P.M.; Bolton, E.J.; Junginger, T.; Morris, D.L., 1999:
Interleukin-6 and tumor necrosis factor-alpha levels following hepatic cryotherapy: association with volume and duration of freezing

Kinugawa, T.; Kato, M.; Ogino, K.; Osaki, S.; Tomikura, Y.; Igawa, O.; Hisatome, I.; Shigemasa, C., 2002:
Interleukin-6 and tumor necrosis factor-alpha levels increase in response to maximal exercise in patients with chronic heart failure

Kato, A.; Ohashi, Y.; Masamoto, T.; Sakamoto, H.; Uekawa, M.; Nakai, Y., 1999:
Interleukin-6 and tumour necrosis factor alpha synthesized by cholesteatoma cells affect mucociliary function in the eustachian tube

Ashcroft, G.S.; Masterson, G.R., 1994:
Interleukin-6 and wound healing

Gurwitz, D., 1998:
Interleukin-6 attenuation of scopolamine-induced amnesia: plausible involvement of cholinergic neuronal survival

Fu, J.; Zheng, J.; Fang, W., 1997:
Interleukin-6 behaves as an autocrine growth stimulator for a human lung giant cell carcinoma cell line

Belluco, C.; Nitti, D.; Frantz, M.; Toppan, P.; Basso, D.; Plebani, M.; Lise, M.; Jessup, J.M., 2000:
Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer

Ohe, Y.; Podack, E.R.; Olsen, K.J.; Miyahara, Y.; Miura, K.; Saito, H.; Koishihara, Y.; Ohsugi, Y.; Ohira, T.; Nishio, K., 1993:
Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumour growth rate but cause weight loss and shortened survival in syngeneic mice

Stelmasiak, Z.; Kozioł-Montewka, M.; Dobosz, B.; Rejdak, K.; Bartosik-Psujek, H.; Mitosek-Szewczyk, K.; Belniak-Legieć, E., 2001:
Interleukin-6 concentration in serum and cerebrospinal fluid in multiple sclerosis patients

Onal, E.E.; Kitapçi, F.; Dilmen, U.; Adam, B., 1999:
Interleukin-6 concentrations in neonatal sepsis

Stasenko, A.A.; Skums, A.V.; Dronov, A.I., 2002:
Interleukin-6 content in the blood serum and bile duct in patients with obturative jaundice of different origin

Tamura, K.; Kawaguchi, T.; Hara, T.; Takatoshi, S.; Tohei, A.; Miyajima, A.; Seishi, T.; Kogo, H., 2001:
Interleukin-6 decreases estrogen production and messenger ribonucleic acid expression encoding aromatase during in vitro cytodifferentiation of rat granulosa cell

Biffl, W.L.; Moore, E.E.; Moore, F.A.; Barnett, C.C.; Carl, V.S.; Peterson, V.N., 1996:
Interleukin-6 delays neutrophil apoptosis

Sawa, Y.; Ichikawa, H.; Kagisaki, K.; Ohata, T.; Matsuda, H., 1998:
Interleukin-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium

Stratakis, C.A.; Mastorakos, G.; Chrousos, G.P., 1994:
Interleukin-6 elevation in critically ill infants with sepsis and necrotizing enterocolitis

Hallbeck, A.L.; Walz, T.M.; Wasteson, A., 2002:
Interleukin-6 enhances transforming growth factor-alpha mRNA expression in macrophage-like human monocytoid (U-937-1) cells

Van Wagoner, N.J.; Benveniste, E.N., 2000:
Interleukin-6 expression and regulation in astrocytes

Ma, X.; Chen, Z.; Zheng, H.; Huang, B.; Cai, L., 2001:
Interleukin-6 gene cloning, expression and purification

Sun, R., 1993:
Interleukin-6 gene expression of human fetal islets and its relation to insulin secretion

Georges, J.L.; Loukaci, V.; Poirier, O.; Evans, A.; Luc, G.; Arveiler, D.; Ruidavets, J.B.; Cambien, F.; Tiret, L., 2001:
Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: the ECTIM study. Etude Cas-Témoin de l'Infarctus du Myocarde

Konttinen, Y.T.; Xu, J.W.; Waris, E.; Li, T.F.; Gómez-Barrena, E.; Nordsletten, L.; Santavirta, S., 2002:
Interleukin-6 in aseptic loosening of total hip replacement prostheses

Graeve, L.; Baumann, M.; Heinrich, P.C., 1993:
Interleukin-6 in autoimmune disease. Role of IL-6 in physiology and pathology of the immune defense

Benda, B.; Korsgren, O., 2001:
Interleukin-6 in islet xenograft rejection

Treon, S.P.; Anderson, K.C., 1998:
Interleukin-6 in multiple myeloma and related plasma cell dyscrasias

Thaler, J.; Fechner, F.; Herold, M.; Huber, H., 1994:
Interleukin-6 in multiple myeloma: correlation with disease activity and Ki-67 proliferation index

Euler, G.J.; Miller, G.A.; Hutter, J.W.; D'Alesandro, M.M., 1998:
Interleukin-6 in neutrophils from peripheral blood and inflammatory periradicular tissues

Likhvantseva, V.G.; Slepova, O.S.; Gerasimenko, V.A., 1998:
Interleukin-6 in patients with uveal melanoma

Malecaze, F.; Simorre, V.; Chollet, P.; Tack, J.L.; Muraine, M.; L.G.ellec, D.; Vita, N.; Arne, J.L.; Darbon, J.M., 1997:
Interleukin-6 in tear fluid after photorefractive keratectomy and its effects on keratocytes in culture

Hernigou, P.; Intrator, L.; Bahrami, T.; Bensussan, A.; Farcet, J.P., 2000:
Interleukin-6 in the blood of patients with total hip arthroplasty without loosening

Tran, D.D., 1993:
Interleukin-6 in the early assessment of acute pancreatitis

Biffl, W.L.; Moore, E.E.; Moore, F.A.; Peterson, V.M., 1996:
Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?

Matsuda, Y.; Kawata, S.; Nagase, T.; Maeda, Y.; Yamasaki, E.; Kiso, S.; Ishiguro, H.; Matsuzawa, Y., 1994:
Interleukin-6 in transcatheter arterial embolization for patients with hepatocellular carcinoma. Effects of serine protease inhibitor

Lin, D.L.; Whitney, M.C.; Yao, Z.; Keller, E.T., 2001:
Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression

Reittie, J.E.; Yong, K.L.; Panayiotidis, P.; Hoffbrand, A.V., 1996:
Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B-chronic lymphocytic leukaemia

Weinhold, B.; Bader, A.; Poli, V.; Rüther, U., 1997:
Interleukin-6 is necessary, but not sufficient, for induction of the humanC-reactive protein gene in vivo

Lemke, R.; Härtig, W.; Rossner, S.; Bigl, V.; Schliebs, R., 1998:
Interleukin-6 is not expressed in activated microglia and in reactive astrocytes in response to lesion of rat basal forebrain cholinergic system as demonstrated by combined in situ hybridization and immunocytochemistry

Bernad, A.; Kopf, M.; Kulbacki, R.; Weich, N.; Koehler, G.; Gutierrez-Ramos, J.C., 1994:
Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system

Ahmad, L.; Parkes, A.; Lazarus, J.; Bartalena, L.; Martino, E.; Diamond, E.; Stagnaro-Green, A., 1998:
Interleukin-6 levels are not increased in women with postpartum thyroid dysfunction

Cooker, L.A.; Luneburg, P.; Holmes, C.J.; Jones, S.; Topley, N., 2002:
Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate/lactate-based peritoneal dialysis solutions

Komoda, H.; Tanaka, Y.; Honda, M.; Matsuo, Y.; Hazama, K.; Takao, T., 1998:
Interleukin-6 levels in colorectal cancer tissues

Hauser, G.J.; Ben-Ari, J.; Colvin, M.P.; Dalton, H.J.; Hertzog, J.H.; Bearb, M.; Hopkins, R.A.; Walker, S.M., 1998:
Interleukin-6 levels in serum and lung lavage fluid of children undergoing open heart surgery correlate with postoperative morbidity

Turner, K.; Pflugfelder, S.C.; Ji, Z.; Feuer, W.J.; Stern, M.; Reis, B.L., 2000:
Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion

Wu, Y.; Zhao, C.; Zhang, J., 2003:
Interleukin-6 levels in the gingival crevicular fluid before and after periodontal treatment

Galazios, G.; Papazoglou, D.; Giagloglou, K.; Vassaras, G.; Maltezos, E.; Anastasiadis, P., 2002:
Interleukin-6 levels in umbilical artery serum in normal and abnormal pregnancies

Kaizu, Y.; Kimura, M.; Yoneyama, T.; Miyaji, K.; Hibi, I.; Kumagai, H., 1998:
Interleukin-6 may mediate malnutrition in chronic hemodialysis patients

Rancourt, C.; Piché, A.; Gomez-Navarro, J.; Wang, M.; Alvarez, R.D.; Siegal, G.P.; Fuller, G.M.; Jones, S.A.; Curiel, D.T., 1999:
Interleukin-6 modulated conditionally replicative adenovirus as an antitumor/cytotoxic agent for cancer therapy

Weihua, X.; Hu, J.; Roy, S.K.; Mannino, S.B.; Kalvakolanu, D.V., 2000:
Interleukin-6 modulates interferon-regulated gene expression by inducing the ISGF3 gamma gene using CCAAT/enhancer binding protein-beta(C/EBP-beta)

Cohen-Kaminsky, S.; Devergne, O.; Delattre, R.M.; Klingel-Schmitt, I.; Emilie, D.; Galanaud, P.; Berrih-Aknin, S., 1993:
Interleukin-6 overproduction by cultured thymic epithelial cells from patients with myasthenia gravis is potentially involved in thymic hyperplasia

Biffl, W.L.; Moore, E.E.; Moore, F.A.; Carl, V.S.; Kim, F.J.; Franciose, R.J., 1994:
Interleukin-6 potentiates neutrophil priming with platelet-activating factor

Bologa, R.M.; Levine, D.M.; Parker, T.S.; Cheigh, J.S.; Serur, D.; Stenzel, K.H.; Rubin, A.L., 1998:
Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients

Mendoza, C.E.; Rosado, M.F.; Pacheco, P., 2001:
Interleukin-6 production and recurrent cardiac myxoma

Rubio, N.; Sierra, A., 1993:
Interleukin-6 production by brain tissue and cultured astrocytes infected with Theiler's murine encephalomyelitis virus

Chen, F-Hong.; Crist, S.A.; Zhang, G-Jian.; Iwamoto, Y.; See, W.A., 2002:
Interleukin-6 production by human bladder tumor cell lines is up-regulated by bacillus Calmette-Guérin through nuclear factor-kappaB and Ap-1 via an immediate early pathway

Tiggelman, A.M.; Boers, W.; Linthorst, C.; Brand, H.S.; Sala, M.; Chamuleau, R.A., 1995 :
Interleukin-6 production by human liver (myo)fibroblasts in culture. Evidence for a regulatory role of LPS, IL-1 beta and TNF alpha

Baqui, A.A.; Meiller, T.F.; Chon, J.J.; Turng, B.F.; Falkler, W.A., 1999:
Interleukin-6 production by human monocytes treated with granulocyte-macrophage colony-stimulating factor in the presence of lipopolysaccharide of oral microorganisms

Reichner, J.S.; Mulligan, J.A.; Palla, M.E.; Hixson, D.C.; Albina, J.E.; Bland, K.I., 1996:
Interleukin-6 production by rat hepatocellular carcinoma cells is associated with metastatic potential but not with tumorigenicity

Beharka, A.A.; Meydani, M.; Wu, D.; Leka, L.S.; Meydani, A.; Meydani, S.N., 2001:
Interleukin-6 production does not increase with age

Imaizumi, E.; Hirata, J.; Tode, T.; Kikuchi, Y.; Nagata, I., 1993:
Interleukin-6 production in endometriosis

Abe, T.; Oka, M.; Tangoku, A.; Hayashi, H.; Yamamoto, K.; Yahara, N.; Morita, K.; Tabata, T.; Ohmoto, Y., 2001:
Interleukin-6 production in lung tissue after transthoracic esophagectomy

Lee, S.Ok.; Lou, W.; Hou, M.; de Miguel, F.; Gerber, L.; Gao, A.C., 2003:
Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells

Chebath, J.; Fischer, D.; Kumar, A.; Oh, J.W.; Kolett, O.; Lapidot, T.; Fischer, M.; Rose-John, S.; Nagler, A.; Slavin, S.; Revel, M., 1998:
Interleukin-6 receptor-interleukin-6 fusion proteins with enhanced interleukin-6 type pleiotropic activities

Pelliniemi, T.T.; Pulkki, K., 1996:
Interleukin-6 reflects the disease severity and prognosis of myeloma

Harmon, G.D.; Senagore, A.J.; Kilbride, M.J.; Warzynski, M.J., 1994 :
Interleukin-6 response to laparoscopic and open colectomy

Tseng, J.F.; Ryan, I.P.; Milam, T.D.; Murai, J.T.; Schriock, E.D.; Landers, D.V.; Taylor, R.N., 1996:
Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis

Baumann, H.; Morella, K.K.; Campos, S.P., 1993:
Interleukin-6 signal communication to the alpha 1-acid glycoprotein gene, but not junB gene, is impaired in HTC cells

Pratt, S.L.; Ogle, C.K.; Mao, J.X.; Zhao, W.; Lovell, G.; Horseman, N.D., 2000:
Interleukin-6 signal transduction in human intestinal epithelial cells

Stephanou, A.; Handwerger, S., 1994:
Interleukin-6 stimulates placental lactogen expression by human trophoblast cells

Jyonouchi, S.C.; Valyasevi, R.W.; Harteneck, D.A.; Dutton, C.M.; Bahn, R.S., 2001:
Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy

de Martino, M.; Rossi, M.E.; Azzari, C.; Chiarelli, F.; Galli, L.; Vierucci, A., 1999:
Interleukin-6 synthesis and IgE overproduction in children with perinatal human immunodeficiency virus-type 1 infection

Graf, M.R.; Merchant, R.E., 2000:
Interleukin-6 transduction of a rat T9 glioma clone results in attenuated tumorigenicity and induces glioma immunity in Fischer F344 rats

Deaciuc, I.V.; Alappat, J.M.; McDonough, K.H.; D'Souza, N.B., 1996:
Interleukin-6 tumor necrosis factor-alpha clearance and metabolism in vivo and by the isolated, perfused liver in the rat: effect of acute alcohol administration

Masera, R.G.; Dovio, A.; Sartori, M.L.; Racca, S.; Angeli, A., 2001:
Interleukin-6 upregulates glucocorticoid receptor numbers in human osteoblast-like cells

Pourcyrous, M.; Korones, S.B.; Crouse, D.; Bada, H.S., 1998:
Interleukin-6, C-reactive protein, and abnormal cardiorespiratory responses to immunization in premature infants

Reyes-Ortiz, C.A., 1999:
Interleukin-6, depression, and hypocholesterolemia

Oh, J-Won.; Lee, H-Baik.; Park, I-Kyu.; Kang, J-Oak., 2002:
Interleukin-6, interleukin-8, interleukin-11, and interferon-gamma levels in nasopharyngeal aspirates from wheezing children with respiratory syncytial virus or influenza A virus infection

McMillan, D.C.; Graham, A.F.; Smith, J.; Wotherspoon, H.A.; Fearon, K.C.; McArdle, C.S., 1994:
Interleukin-6, neutrophilia and the acute phase protein response in colorectal cancer patients

Genesca, J.; Gonzalez, A.; Segura, R.; Catalan, R.; Marti, R.; Varela, E.; Cadelina, G.; Martinez, M.; Lopez-Talavera, J.C.; Esteban, R.; Groszmann, R.J.; Guardia, J., 1999:
Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis

Janota, J.; Stranák, Z.; Bĕlohlávková, S., 2001:
Interleukin-6, procalcitonin, C-reactive protein and the immature to total neutrophil ratio (I/T) in the diagnosis of early-onset sepsis in low birth weight neonates

Franke, S.; Herrmann, D.; Hein, G.; Müller, A.; Stein, G., 1997:
Interleukin-6, soluble interleukin-2-receptor and soluble interleukin-6-receptor in sera of patients with rheumatoid arthritis: influences of disease activity and drug therapy

Komorowska-Pietrzykowska, R.; Rajewski, A.; Sobieska, M.; Wiktorowicz, K., 2002:
Interleukin-6, tumor necrosis factor alpha and interferon gamma in patients with anorexia nervosa

Spicka, I.; Masek, Z.; Jirsa, M.; Zounar, R.; Procházka, B.; Merta, M.; Cieslar, P.; Tesar, V.; Klener, P., 1998:
Interleukin-6, tumor necrosis factor alpha and their soluble receptors in Bence-Jones nephropathy. Possible role in pathogenesis andthe importance in the determination of prognosis in renal insufficiency

Niehof, M.; Streetz, K.; Rakemann, T.; Bischoff, S.C.; Manns, M.P.; Horn, F.; Trautwein, C., 2000:
Interleukin-6-induced tethering of STAT3 to the LAP/C/EBPbeta promoter suggests a new mechanism of transcriptional regulation by STAT3

Lee, Y.H.; Bae, S.S.; Seo, J.K.; Choi, I.; Ryu, S.H.; Suh, P.G., 2000:
Interleukin-6-induced tyrosine phosphorylation of phospholipase C-gamma1 in PC12 cells

Dubost, J-Jacques.; Rolhion, C.; Tchirkov, A.; Bertrand, S.; Chassagne, J.; Dosgilbert, A.; Verrelle, P., 2002:
Interleukin-6-producing cells in a human glioblastoma cell line are not affected by ionizing radiation

Taguchi, Y.; Yamamoto, M.; Yamate, T.; Lin, S.C.; Mocharla, H.; DeTogni, P.; Nakayama, N.; Boyce, B.F.; Abe, E.; Manolagas, S.C., 1998:
Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage

Yokoyama, A.; Hiwada, K., 2000:
Interleukin-6/soluble interleukin-6 receptor

Lotz, M., 1995:
Interleukin-6: a comprehensive review

Ferrari, R., 2001:
Interleukin-6: a neurohumoral predictor of prognosis in patients with heart failure: light and shadow

Girasole, G.; Passeri, G.; Pedrazzoni, M.; Giuliani, N.; Passeri, M., 1995:
Interleukin-6: a pathogenetic role in the postmenopausal osteoporosis?

Wirtz, D.C.; Heller, K.D.; Miltner, O.; Zilkens, K.W.; Wolff, J.M., 2000:
Interleukin-6: a potential inflammatory marker after total joint replacement

Seymour, J.F.; Kurzrock, R., 1996:
Interleukin-6: biologic properties and role in lymphoproliferative disorders

Fogarasi, M.; Kubala, E.; Bíró, J.; Falus, A.; Nemesánszky, E., 1994:
Interleukin-6: friend or enemy? Latest findings on the clinical aspects of IL-6

Papanicolaou, D.A.; Vgontzas, A.N., 2000:
Interleukin-6: the endocrine cytokine

Maeurer, M.J.; Lotze, M.T., 1998:
Interleukin-7 (IL-7) knockout mice. Implications for lymphopoiesis and organ-specific immunity

Fry, T.J.; Mackall, C.L., 2002:
Interleukin-7 and immunorestoration in HIV: beyond the thymus

Appasamy, P.M., 1995:
Interleukin-7 and lymphopoiesis: biological and clinical implications

Leong, K.H.; Ramshaw, I.A.; Ramsay, A.J., 1997:
Interleukin-7 enhances cell-mediated immune responses in vivo in an interleukin-2-dependent manner

Fratazzi, C.; Carini, C., 1997:
Interleukin-7 modulates CD23 and HLA-DR expression on CD4+ T cells and promotes a Th-2 type citokine profile

He, Y.W.; Malek, T.R., 1996:
Interleukin-7 receptor alpha is essential for the development of gamma delta + T cells, but not natural killer cells

Varas, A.; Vicente, A.; Jiménez, E.; Alonso, L.; Moreno, J.; Muñoz, J.J.; Zapata, A.G., 1998:
Interleukin-7 treatment promotes the differentiation pathway of T-cell-receptor-alpha beta cells selectively to the CD8+ cell lineage

Ishida, H., 2000:
Interleukin-7, 8, 9, 10

Mertsching, E.; Meyer, V.; Linares, J.; Lombard-Platet, S.; Ceredig, R., 1998:
Interleukin-7, a non-redundant potent cytokine whose over-expression massively perturbs B-lymphopoiesis

Trümper, L.; Jung, W.; Dahl, G.; Diehl, V.; Gause, A.; Pfreundschuh, M., 1994:
Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease

Möller, P.; Böhm, M.; Czarnetszki, B.M.; Schadendorf, D., 1996:
Interleukin-7. Biology and implications for dermatology

Orlic, D.; Girard, L.J.; Lee, D.; Anderson, S.M.; Puck, J.M.; Bodine, D.M., 1997:
Interleukin-7R alpha mRNA expression increases as stem cells differentiate into T and B lymphocyte progenitors

Boratyńska, M.; Boratyński, J., 1999:
Interleukin-8 (IL-8) and lipid disorders in chronic renal graft rejection

Mukaida, N.; Harada, A.; Matsushima, K., 1998:
Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions

Kirk, G.; Hickman, P.; McLaren, M.; Stonebridge, P.A.; Belch, J.J., 1999:
Interleukin-8 (IL-8) may contribute to the activation of neutrophils in patients with peripheral arterial occlusive disease (PAOD)

Inoue, H., 1999:
Interleukin-8 and airway inflammation

Huang, Y.S.; Wu, J.C.; Chang, F.Y.; Lee, S.D., 1999:
Interleukin-8 and alcoholic liver disease

Chung, R.M.; Grbíc, J.T.; Lamster, I.B., 1997:
Interleukin-8 and beta-glucuronidase in gingival crevicular fluid

Lu, C.Y.; Tang, Z.S., 1993:
Interleukin-8 and inflammation

Segura, R.M.; Alegre, J.; Varela, E.; Marti, R.; Suriñach, J.M.; Jufresa, J.; Armadans, L.; Pascual, C.; Fernández de Sevilla, T., 1998:
Interleukin-8 and markers of neutrophil degranulation in pleural effusions

Elner, V.M.; Burnstine, M.A.; Kunkel, S.L.; Strieter, R.M.; Elner, S.G., 1998:
Interleukin-8 and monocyte chemotactic protein-1 gene expression and protein production by human orbital fibroblasts

Hermouet, S.; Corre, I.; Lippert, E., 2000:
Interleukin-8 and other agonists of Gi2 proteins: autocrine paracrine growth factors for human hematopoietic progenitors acting in synergy with colony stimulating factors

Baggiolini, M.; Dewald, B.; Moser, B., 1994:
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines

Brew, R.; Erikson, J.S.; West, D.C.; Flanagan, B.F.; Christmas, S.E., 1997:
Interleukin-8 as a growth factor for human colorectal carcinoma cells in vitro

Lin, K.J.; Lin, J.; Hanasawa, K.; Tani, T.; Kodama, M., 2000:
Interleukin-8 as a predictor of the severity of bacteremia and infectious disease

Arici, A.; Tazuke, S.I.; Attar, E.; Kliman, H.J.; Olive, D.L., 1996:
Interleukin-8 concentration in peritoneal fluid of patients with endometriosis and modulation of interleukin-8 expression in human mesothelial cells

Nassif, P.S.; Simpson, S.Q.; Izzo, A.A.; Nicklaus, P.J., 1997:
Interleukin-8 concentration predicts the neutrophil count in middle ear effusion

Miyoshi, T.; Fukagawa, K.; Shimmura, S.; Fujishima, H.; Takano, Y.; Takamura, E.; Tsubota, K.; Saito, H.; Oguchi, Y., 2001:
Interleukin-8 concentrations in conjunctival epithelium brush cytology samples correlate with neutrophil, eosinophil infiltration, and corneal damage

Arici, A.; Oral, E.; Bukulmez, O.; Buradagunta, S.; Engin, O.; Olive, D.L., 1996:
Interleukin-8 expression and modulation in human preovulatory follicles and ovarian cells

Kim, J.S.; Jung, H.C.; Kim, J.M.; Song, I.S.; Kim, C.Y., 1999:
Interleukin-8 expression by human neutrophils activated by Helicobacter pylori soluble proteins

Garcia-Velasco, J.A.; Arici, A., 1999:
Interleukin-8 expression in endometrial stromal cells is regulated by integrin-dependent cell adhesion

Becker, S.; Koren, H.S.; Henke, D.C., 1993:
Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-6

Maxwell, K.S.; Fitzgerald, J.E.; Burleson, J.A.; Leonard, G.; Carpenter, R.; Kreutzer, D.L., 1994:
Interleukin-8 expression in otitis media

Budde, K.; Waiser, J.; Ceska, M.; Katalinic, A.; Kürzdörfer, M.; Neumayer, H.H., 1997 :
Interleukin-8 expression in patients after renal transplantation

Nagaoka, S.; Tokuda, M.; Sakuta, T.; Taketoshi, Y.; Tamura, M.; Takada, H.; Kawagoe, M., 1996:
Interleukin-8 gene expression by human dental pulp fibroblast in cultures stimulated with Prevotella intermedia lipopolysaccharide

Vinante, F.; Rigo, A.; Cassatella, M.A.; Pizzolo, G., 1999:
Interleukin-8 in acute myeloid leukemia

McColm, J.R.; McIntosh, N., 1994:
Interleukin-8 in bronchoalveolar lavage samples as predictor of chronic lung disease in premature infants

Ostergaard, C.; Benfield, T.L.; Sellebjerg, F.; Kronborg, G.; Lohse, N.; Lundgren, J.D., 1996:
Interleukin-8 in cerebrospinal fluid from patients with septic and aseptic meningitis

Hotomi, M.; Samukawa, T.; Yamanaka, N., 1994:
Interleukin-8 in otitis media with effusion

Groneck, P.; Speer, C.P., 1993:
Interleukin-8 in pulmonary effluent fluid of preterm infants

Yamamoto, C.; Yoneda, T.; Yoshikawa, M.; Fu, A.; Tokuyama, T.; Okamoto, Y.; Nakaya, M.; Tsukaguchi, K.; Kunimatsu, M.; Narita, N., 1996:
Interleukin-8 in sputum from patients with pulmonary emphysema

Shute, J., 1994:
Interleukin-8 is a potent eosinophil chemo-attractant

Reimund, J.M.; Duclos, B.; Dumont, S.; Muller, C.; Baumann, R.; Poindron, P., 1997:
Interleukin-8 is an important inflammatory mediator in hemorrhagic rectocolitis and Crohn disease

Whalen, M.J.; Carlos, T.M.; Kochanek, P.M.; Wisniewski, S.R.; Bell, M.J.; Clark, R.S.; DeKosky, S.T.; Marion, D.W.; Adelson, P.D., 2000:
Interleukin-8 is increased in cerebrospinal fluid of children with severe head injury

Chávez, E.; Sarmiento, F.; López, M.; Kakarieka, E.; Vial, M.T.; Gotteland, M., 1998:
Interleukin-8 levels in gastric biopsies of children colonized by Helicobacter pylori

John, A.E.; Galea, J.; Francis, S.E.; Holt, C.M.; Finn, A., 1999:
Interleukin-8 mRNA expression in circulating leucocytes during cardiopulmonary bypass

Yatsunami, J.; Tsuruta, N.; Ogata, K.; Wakamatsu, K.; Takayama, K.; Kawasaki, M.; Nakanishi, Y.; Hara, N.; Hayashi, S., 1998:
Interleukin-8 participates in angiogenesis in non-small cell, but not small cell carcinoma of the lung

Ogura, K.; Takahashi, M.; Maeda, S.; Ikenoue, T.; Kanai, F.; Yoshida, H.; Shiratori, Y.; Mori, K.; Mafune, K.I.; Omata, M., 1999:
Interleukin-8 production in primary cultures of human gastric epithelial cells induced by Helicobacter pylori

Ben-Abraham, R.; Weinbroum, A.A.; Lotan, D.; Dagan, O.; Schreriber-Scheffer, R.; Mishali, D.; Harel, R.; Vishne, T.; Barzilay, Z.; Paret, G., 2002:
Interleukin-8 secretion following cardiopulmonary bypass in children as a marker of early postoperative morbidity

Krüger, S.; Brandt, E.; Klinger, M.; Kreft, B., 1999:
Interleukin-8 secretion of cortical tubular epithelial cells is directed to the basolateral environment and is not enhanced by apical exposure to Escherichia coli

Moutabarrik, A.; Nakanishi, I.; Kameoka, H.; Takahara, S.; Kokado, Y.; Ishibashi, M.; Sonoda, T., 1994:
Interleukin-8 serum and urine concentrations after kidney transplantation

Wang, Y.; Baier, J.; Adair, C.D.; Lewis, D.F.; Krueger, S.; Kruger, T.; Gurski, M.; Brown, E., 2000:
Interleukin-8 stimulates placental prostacyclin production in preeclampsia

Kitamura, K., 1995:
Interleukin-8, 9 (IL-8, IL-9)

Xie, H.; Cao, C.; Ma, D., 1997:
Interleukin-8, a regulator of inflammation in gingival crevicular fluid

Schmalstieg, F.C.; Chow, J.; Savage, C.; Rudloff, H.E.; Palkowetz, K.H.; Zwischenberger, J.B., 2001:
Interleukin-8, aquaporin-1, and inducible nitric oxide synthase in smoke and burn injured sheep treated with percutaneous carbon dioxide removal

Sherwood, E.R.; Prough, D.S., 2000:
Interleukin-8, neuroinflammation, and secondary brain injury

Smart, S.J.; Casale, T.B., 1993:
Interleukin-8-induced transcellular neutrophil migration is facilitated by endothelial and pulmonary epithelial cells

Mukaida, N., 2001:
Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation

Lemoli, R.M.; Fortuna, A.; Tafuri, A.; Grande, A.; Amabile, M.; Martinelli, G.; Ferrari, S.; Tura, S., 1997:
Interleukin-9 in human myeloid leukemia cells

Orabona, C.; Dumoutier, L.; Renauld, J.C., 2001:
Interleukin-9 induces 24P3 lipocalin gene expression in murine T cell lymphomas

Arras, M.; Huaux, F.; Vink, A.; Delos, M.; Coutelier, J.P.; Many, M.C.; Barbarin, V.; Renauld, J.C.; Lison, D., 2001:
Interleukin-9 reduces lung fibrosis and type 2 immune polarization induced by silica particles in a murine model

Renauld, J.C., 1995:
Interleukin-9: structural characteristics and biologic properties

Salgado, F.J.; Lojo, J.; Fernández-Alonso, C.M.; Viñuela, J.; Cordero, O.J.; Nogueira, M., 2002:
Interleukin-dependent modulation of HLA-DR expression on CD4and CD8 activated T cells

Arock, M., 1996:
Interleukine-3: a multifunctional cytokine

Menet, E.; Corbi, P.; Ancey, C.; Morel, F.; Delwail, A.; Garcia, M.; Osta, A.M.; Wijdenes, J.; Potreau, D.; Lecron, J.C., 2002:
Interleukine-6 (IL-6) synthesis and gp130 expression by human pericardium

Vetillard, J.; Drouet, M.; Neildez-Nguyen, T.M.; Mestries, J.C.; Mathieu, J.; Thierry, D.; Herodin, F., 2000:
Interleukine-8 acts as a strong peripheral blood granulocyte-recruiting agent rather than as a hematopoietic progenitor cell-mobilizing factor

Wilson, A.; Corthésy, P.; Reichenbach, P.; MacDonald, H.R.; Nabholz, M., 1994:
Interleukins (IL)-1 and IL-2 control IL-2 receptor alpha and beta expression in immature thymocytes

Leytin, V.; Shakoor, S.; Mody, M.; Allen, D.; Hannach, B.; Garvey, B.; Freedman, J., 2001:
Interleukins 1beta, 6, 8 and tumour necrosis factor alpha do not induce platelet activation

Paleri, V.; Pulimood, A.; Davies, G.R.; Birchall, M.A., 2001:
Interleukins 7 and 12 are expressed in head and neck squamous cancer

Guidet, B.; Staikowsky, F.; Offenstadt, G., 1993:
Interleukins and TNF in septic shock

Rothwell, N.J.; Loddick, S.A.; Stroemer, P., 1997:
Interleukins and cerebral ischaemia

Hassan, H.T.; Drexler, H.G., 1995:
Interleukins and colony stimulating factors in human myeloid leukemia cell lines

Nikolov, R.; Lazarov, S., 2002:
Interleukins and endocrine function

González Moreno, J.; Hernández Mora, F.J.; Vargas Rodríguez, R.; Plascencia Hernández, A.; Guzmán Sánchez, A., 1994:
Interleukins and pregnancy: a disputed reality

Messmann, H.; Vogt, W.; Falk, W.; Vogl, D.; Zirngibl, H.; Leser, H.G.; Schölmerich, J., 1998:
Interleukins and their antagonists but not TNF and its receptors are released in post-ERP pancreatitis

Bilyk, N.M., 2001:
Interleukins as highly informative markers of the activity of the inflammatory process of the adnexa uteri

Loginov, A.S.; Tsaregorodtseva, T.M.; Zotina, M.M.; Serova, T.I.; Iakimchuk, G.N.; Fedotova, T.F., 2001:
Interleukins in chronic viral hepatitis

Sokolova, G.N.; Tsaregorodtseva, T.M.; Zotina, M.M.; Dubtsova, E.A., 2002:
Interleukins in stomach and duodenal ulcers

Mavridis, A.K.; Tsiara, S.; Makis, A.; Chaidos, A.; Christou, L.; Seferiadis, K.; Bourantas, K.L., 1999:
Interleukins, TNF-alpha and beta-2M in patients with B cell chronic lymphocytic leukemia

Chybicka, A., 1994:
Interleukins--biological functions and clinical use

Wheeler, V.S., 1996:
Interleukins: the search for an anticancer therapy

Petrov; Shik, 1993:
Interlevel optical transitions in quantum wells

Radchenko, A.N., 2002:
Interlevel relations in neural memory: extrasynaptic reception of mediators, potentiation, and spontaneous activity

Riordan, M.L.; Perry, G.J., 1999:
Interlibrary cooperation: from ILL to IAIMS and beyond

McKnight, M., 2000:
Interlibrary loan availability of nursing journals through DOCLINE and OCLC: a five-state survey

Dudden, R.F.; Coldren, S.; Condon, J.E.; Katsh, S.; Reiter, C.M.; Roth, P.L., 2000:
Interlibrary loan in primary access libraries: challenging the traditional view

Lingle, V.A.; Malcom, D.L., 1990:
Interlibrary loan management with microcomputers: a descriptive comparison of software

Steuben, J., 1979:
Interlibrary loan of photocopies of articles under the new copyright law

Kilgour, F.G., 1979:
Interlibrary loans on-line

Rojas-González, P.X.; Castiñeiras, A.; González-Pérez, J.M.; Choquesillo-Lazarte, D.; Niclós-Gutiérrez, J., 2002:
Interligand interactions controlling the mu-N7,N9-metal bonding of adenine (AdeH) to the N-benzyliminodiacetato(2-) copper(II) chelate and promoting the N9 versus N3 tautomeric proton transfer: molecular and crystal structure of [Cu2(NBzIDA)(2)(H2O)(2)(mu-N7,N9-Ade(N3)H)].(3)H2O

Swinnen, S.P.; Van Langendonk, L.; Verschueren, S.; Peeters, G.; Dom, R.; D.W.erdt, W., 1997:
Interlimb coordination deficits in patients with Parkinson's disease during the production of two-joint oscillations in the sagittal plane

Donker, S.F.; Beek, P.J., 2002:
Interlimb coordination in prosthetic walking: effects of asymmetry and walking velocity

Van Emmerik, R.E.; Wagenaar, R.C.; Van Wegen, E.E., 1999:
Interlimb coupling patterns in human locomotion: are we bipeds or quadrupeds?

Kolesnikova, T.D.; Koriakov, D.E.; Semeshin, V.F.; Beliaeva, E.S.; Zhimulev, I.F., 2002:
Interline differences in morphology of the precentromeric region of polytene X-chromosome in Drosophila melanogaster salivary glands

Gusev, E.Iu.; Kevorkov, N.N.; Ponosov, V.L., 1994:
Interline features of secondary immune response in mice

Razorenova, O.V.; Karpova, N.N.; Smirnova, I.B.; Kusulidu, L.K.; Reneva, N.K.; Subocheva, E.A.; Kim, A.I.; Liubomirskaia, N.V.; Il'in, I.V., 2001:
Interlineage distribution and characteristics of the structure of two subfamilies of Drosophila melanogaster MDG4 (gypsy) retrotransposon

Stockley, K.B.; Green, W.B., 2000:
Interlist equivalency of the Northwestern University Auditory Test No. 6 in quiet and noise with adult hearing-impaired individuals

Yamanaka, A.; Hirai, T.; Takahashi, A.; Konishi, F., 2002:
Interlobar lymph node metastases according to primary tumor location in lung cancer

Kang, E.Y.; Grenier, P.; Laurent, F.; Müller, N.L., 1996:
Interlobular septal thickening: patterns at high-resolution computed tomography

Raymo, Fçisco.M.; Stoddart, J.Fraser., 2002:
Interlocked Macromolecules

Baixauli, F.; Baixauli, E.J.; Sánchez-Alepuz, E.; Baixauli, F., 1998:
Interlocked intramedullary nailing for treatment of open femoral shaft fractures

Sultan, S., 2002:
Interlocked nailing of comminuted fractures shaft of femur